Home
  >  
Section 9

EurekaMag Full Text Articles Chapter 8,900



References:

Meloni, G.; Foa, R.; Vignetti, M.; Guarini, A.; Fenu, S.; Tosti, S.; Tos, A.G.; Mandelli, F. 1994: Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood 84(7): 2158-2163
Plata-Salamán, C.R.; ffrench-Mullen, J.M. 1993: Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport 4(5): 579-581
Nabata, T.; Fukuo, K.; Morimoto, S.; Kitano, S.; Momose, N.; Hirotani, A.; Nakahashi, T.; Nishibe, A.; Hata, S.; Niinobu, T.; Suhara, T.; Shimizu, M.; Ohkuma, H.; Sakurai, S.; Nishimaki, H.; Ogihara, T. 1997: Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells. Atherosclerosis 133(1): 23-30
Pericle, F.; Liu, J.H.; Diaz, J.I.; Blanchard, D.K.; Wei, S.; Forni, G.; Djeu, J.Y. 1994: Interleukin-2 prevention of apoptosis in human neutrophils. European Journal of Immunology 24(2): 440-444
Tsuda, H.; Huang, R.W.; Takatsuki, K. 1993: Interleukin-2 prevents programmed cell death in adult T-cell leukemia cells. Japanese Journal of Cancer Research: Gann 84(4): 431-437
Huang, R.W.; Tsuda, H.; Takatsuki, K. 1993: Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. International Journal of Hematology 58(1-2): 83-92
Rashwan, E., A.; El-Moneim, N., A.A.; Motawei, M., A. 1996: Interleukin-2 production and expression of interleukin-2 receptor by activated peripheral blood T-lymphocytes in Hodgkin's disease. Journal of the Medical Research Institute 17(1): 157-166
Dao, T.; Holán, V.; Minowada, J. 1993: Interleukin-2 production by T cells: a study of the immunoregulatory actions of interferon-alpha, interferon-gamma, and tumor necrosis factor-alpha in phenotypically different T cell clones. Cellular Immunology 151(2): 451-459
Holán, V.; Minowada, J. 1993: Interleukin-2 production by human leukemia cell lines of pre-B cell origin. Neoplasma 40(1): 3-8
Arima, N.; Daitoku, Y.; Hidaka, S.; Yamamoto, Y.; Fujimoto, K.; Matsushita, K.; Ohtsubo, H.; Fukumori, J.; Tanaka, H.; Onoue, K. 1992: Interleukin-2 production by primary adult T cell leukemia tumor cells is macrophage dependent. American Journal of Hematology 41(4): 258-263
Gurbindo, C.; Sabbah, S.; Menezes, J.; Justinich, C.; Marchand, R.; Seidman, E.G. 1993: Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition 17(3): 247-254
Sarder, M.; Saito, H.; Abe, K. 1993: Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Research 625(2): 347-350
Kradin, R.L.; Xia, W.; Pike, M.; Byers, H.R.; Pinto, C. 1996: Interleukin-2 promotes the motility of dendritic cells and their accumulation in lung and skin. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 64(4): 180-186
Fefer, A.; Benyunes, M.; Higuchi, C.; York, A.; Massumoto, C.; Lindgren, C.; Buckner, C.D.; Thompson, J.A. 1993: Interleukin-2 racemic lymphocytes as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies. Acta Haematologica 89(Suppl 1): 2-7
Ryffel, B.; Willcocks, J.L.; Brooks, N.; Woerly, G. 1995: Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: Sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. Immunopharmacology 30(3): 199-207
Nakase, K.; Kita, K.; Otsuji, A.; Anazawa, H.; Shirakawa, S.; Nasu, K.; Dohy, H.; Tsutani, H.; Tanaka, I. 1993: Interleukin-2 receptor alpha chain on acute myelocytic leukemia cells is involved in cell-to-cell interactions. Leukemia Research 17(1): 17-21
Nishizaki, H. 1994: Interleukin-2 receptor alpha(p55) mRNA expression in alveolar lymphocytes of patients with sarcoidosis. Okayama Igakkai Zasshi 106(1-2): 61-70
Panzali, A.; Scalini, L.; Lanfranchi, A.; Cristinelli, L.; Palano, M.G.; Albertini, A.; Maiorca, R. 1995: Interleukin-2 receptor and beta-2 microglobulin levels as a means of monitoring renal allograft recipients. Giornale Italiano di Chimica Clinica 20(1): 31-38
Bani, L.; David, D.; Février, M.; Pialoux, G.; Dupont, B.; Sugamura, K.; Thèze, J. 1997: Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120. European Journal of Immunology 27(9): 2188-2194
Pukhalsky, A.; Toptygina, A.; Khaidukov, S. 1995: Interleukin-2 receptor beta chain as a possible target for low doses of mafosfamide. Mediators of Inflammation 4(3): 175-180
Zaffaroni, M.; Ghezzi, A.; Callea, L.; Zibetti, A. 1992: Interleukin-2 receptor expression on blood monocytes of patients with multiple sclerosis. Italian Journal of Neurological Sciences 13(8): 657-660
Noguchi, M.; Yi, H.; Rosenblatt, H.M.; Filipovich, A.H.; Adelstein, S.; Modi, W.S.; McBride, O.W.; Leonard, W.J. 1993: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73(1): 147-157
Russell, S.M.; Keegan, A.D.; Harada, N.; Nakamura, Y.; Noguchi, M.; Leland, P.; Friedmann, M.C.; Miyajima, A.; Puri, R.K.; Paul, W.E. 1993: Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262(5141): 1880-1883
Tsuge, I.; Matsuoka, H.; Abe, T.; Kamachi, Y.; Torii, S. 1996: Interleukin-2 receptor gamma-chain mutations in severe combined immunodeficiency with B-lymphocytes. European Journal of Pediatrics 155(12): 1018-1024
Aoki, M.; Sanada, A.; Yamamoto, K.; Kawahara, J.; Iwasaki, T.; Usui, M. 1995: Interleukin-2 receptor in peripheral lymphocytes in primary retinitis pigmentosa. Rinsho Ganka 49(4): 653-655
Merkel, P.A.; Dooley, M.A.; Dawson, D.V.; Pisetsky, D.S.; Polisson, R.P. 1996: Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. Journal of Rheumatology 23(11): 1856-1861
Polisson, R.P.; Dooley, M.A.; Dawson, D.V.; Pisetsky, D.S. 1994: Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate. Arthritis and Rheumatism 37(1): 50-56
Miller, D.D.; Bach, R.G.; Tio, F.O.; Bailey, S.R.; Waters, C.A.; Woodworth, T.G.; Nichols, J.C.; Paige, S.B.; Farrar, M. 1996: Interleukin-2 receptor-specific fusion toxin inhibits barotrauma-induced arterial atherosclerosis. Atherosclerosis 126(1): 1-14
Loetscher, P.; Seitz, M.; Baggiolini, M.; Moser, B. 1996: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. Journal of Experimental Medicine 184(2): 569-577
Lapchak, P.A.; Araujo, D.M. 1993: Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus. Neuroreport 4(3): 303-306
Lu, C.Z.; Fredrikson, S.; Xiao, B.G.; Link, H. 1993: Interleukin-2 secreting cells in multiple sclerosis and controls. Journal of the Neurological Sciences 120(1): 99-106
Hsu, S.C.; Glaves, D.; Sood, A.K. 1997: Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential. Cancer Immunology Immunotherapy: Cii 44(2): 117-124
Kindler, V.; Matthes, T.; Jeannin, P.; Zubler, R.H. 1995: Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. European Journal of Immunology 25(5): 1239-1243
Orchard, P.J.; Katsanis, E.; Boyer, M.; May, C.; McIvor, R.S.; Blazar, B.R. 1996: Interleukin-2 secretion by transduced and unselected BDL-2 lymphoma results in increased survival in mice with previously established disseminated disease. Cancer Biotherapy and Radiopharmaceuticals 11(2): 155-164
Einspahr, K.J.; Abraham, R.T.; Dick, C.J.; Leibson, P.J. 1992: Interleukin-2 signal transduction in human NK cells: multisite phosphorylation and activation of the tyrosine kinase p56lck. Journal of Leukocyte Biology 52(5): 565-571
Jones, D.R.; Flores, I.; Díaz, E.; Martinez, C.; Mérida, I. 1998: Interleukin-2 stimulates a late increase in phosphatidic acid production in the absence of phospholipase D activation. Febs Letters 433(1-2): 23-27
Kunert Radek, J.; Radek, A.; Stepien, H. 1994: Interleukin-2 stimulates cell proliferation of the growth hormone producing human pituitary adenoma in vitro. Biomedical Letters 49(196): 259-264
Hillhouse, E.W. 1994: Interleukin-2 stimulates the secretion of arginine vasopressin but not corticotropin-releasing hormone from rat hypothalamic cells in vitro. Brain Research 650(2): 323-325
Gesbert, F.; Garbay, C.; Bertoglio, J. 1998: Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. Journal of Biological Chemistry 273(7): 3986-3993
Nelson, B.J.; Danielpour, D.; Rossio, J.L.; Turpin, J.; Nacy, C.A. 1994: Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-beta. Journal of Leukocyte Biology 55(1): 81-90
Kloosterman, T.C.; Martens, A.C.; Osterwalder, B.; Hagenbeek, A. 1994: Interleukin-2 therapy after allogeneic bone marrow transplantation for acute myelocytic leukemia: studies in a relevant rat model for AML. Bone Marrow Transplantation 14(6): 965-973
Van Oosten, B.W.; Uitdehaag, B.M.; Barkhof, F.; Hartung, H.P.; Wagstaff, J.; Polman, C.H. 1997: Interleukin-2 therapy does not exacerbate multiple sclerosis. Neurology 49(2): 633-634
Hirose, M.; Saito, S.; Yoshimoto, T.; Kuroda, Y. 1995: Interleukin-2 therapy of Langerhans cell histiocytosis. Acta Paediatrica 84(10): 1204-1206
Joshi, S.S.; Messbarger, L.J.; Hao, W. 1994: Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice. Clinical and Experimental Metastasis 12(1): 37-46
Armstrong, J.W.; Balch, S.; Chapes, S.K.; Spooner, B.S. 1994: Interleukin-2 therapy reverses some immunosuppressive effects of skeletal unloading. Journal of Applied Physiology 77(2): 584-589
Garrity, P.A.; Chen, D.; Rothenberg, E.V.; Wold, B.J. 1994: Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Molecular and Cellular Biology 14(3): 2159-2169
Eizenberg, O.; Faber-Elman, A.; Lotan, M.; Schwartz, M. 1995: Interleukin-2 transcripts in human and rodent brains: Possible expression by astrocytes. Journal of Neurochemistry 64(5): 1928-1936
Moody, D.B.; Robinson, J.C.; Ewing, C.M.; Lazenby, A.J.; Isaacs, W.B. 1994: Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo. Prostate 24(5): 244-251
Gisselbrecht, C.; Maraninchi, D.; Pico, J.L.; Milpied, N.; Coiffier, B.; Divine, M.; Tiberghien, P.; Bosly, A.; Tilly, H.; Boulat, O. 1994: Interleukin-2 treatment in lymphoma: a phase II multicenter study. Blood 83(8): 2081-2085
Rizzo, L.V.; Miller-Rivero, N.E.; Chan, C.C.; Wiggert, B.; Nussenblatt, R.B.; Caspi, R.R. 1994: Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. Journal of Clinical Investigation 94(4): 1668-1672
Karnitz, L.M.; Burns, L.A.; Sutor, S.L.; Blenis, J.; Abraham, R.T. 1995: Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Molecular and Cellular Biology 15(6): 3049-3057
Benyunes, M.C.; Massumoto, C.; York, A.; Higuchi, C.M.; Buckner, C.D.; Thompson, J.A.; Petersen, F.B.; Fefer, A. 1993: Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplantation 12(2): 159-163
Slavin, M.; Dobbs, S.; Crawford, S.; Bowden, R. 1993: Interleukin-2, interferon-gamma and natural killer cell activity in bronchoalveolar lavage fluid from marrow transplant recipients with cytomegalovirus pneumonia. Bone Marrow Transplantation 11(2): 113-118
Breese, E.; Braegger, C.P.; Corrigan, C.J.; Walker-Smith, J.A.; MacDonald, T.T. 1993: Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78(1): 127-131
Knight, C.R.; Rees, R.C.; Platts, A.; Johnson, T.; Griffin, M. 1993: Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells. Immunology 79(4): 535-541
Eckert, K.; Grünberg, E.; Immenschuh, P.; Garbin, F.; Kreuser, E.D.; Maurer, H.R. 1997: Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1. Journal of Cancer Research and Clinical Oncology 123(8): 420-428
Bergers, J.J.; Den Otter, W.; Dullens, H.F.; Kerkvliet, C.T.; Crommelin, D.J. 1993: Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines. Pharmaceutical Research 10(12): 1715-1721
Nakakuma, H.; Nagakura, S.; Horikawa, K.; Hidaka, M.; Kawaguchi, T.; Iwamoto, N.; Sanada, I.; Kagimoto, T.; Takatsuki, K. 1994: Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients. Blood 84(1): 309-314
Yamamoto, I.; Adachi, T.; Kishiro, Y.; Fujiwara, M.; Gohda, E. 1997: Interleukin-2-dependent augmentation of the anti-TNP antibody production by sodium butyrate in cultured murine splenic B cells. International Journal of Immunopharmacology 19(6): 347-354
Song, C.; Leonard, B.E. 1995: Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation 2(5): 263-273
Zalcman, S.; Green-Johnson, J.M.; Murray, L.; Wan, W.; Nance, D.M.; Greenberg, A.H. 1994: Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system. Journal of Pharmacology and Experimental Therapeutics 271(2): 977-982
Lentsch, A.B.; Miller, F.N.; Edwards, M.J. 1997: Interleukin-2-induced hepatic injury involves temporal patterns of cell adhesion in the microcirculation. American Journal of Physiology 272(4 Pt 1): G727-G731
Rabinovici, R.; Sofronski, M.D.; Borboroglu, P.; Spirig, A.M.; Hillegas, L.M.; Levine, J.; Vernick, J.; Scesney, S.M.; Feuerstein, N.; Feuerstein, G. 1994: Interleukin-2-induced lung injury. The role of complement. Circulation Research 74(2): 329-335
Quinn, T.D.; Miller, F.N.; Wilson, M.A.; Garrison, R.N.; Anderson, J.A.; Lenz, L.G.; Edwards, M.J. 1994: Interleukin-2-induced lymphocyte infiltration of multiple organs is differentially suppressed by soluble tumor necrosis factor receptor. Journal of Surgical Research 56(2): 117-122
Ruben, L.N.; de Leon, R.T.; Johnson, R.O.; Bowman, S.; Clothier, R.E. 1996: Interleukin-2-induced mortality during the metamorphosis of Xenopus laevis. Immunology Letters 51(3): 157-161
Pozniak, M.A.; Christy, P.S.; Albertini, M.R.; Duffek, S.M.; Schiller, J.H. 1995: Interleukin-2-induced splenic enlargement. Cancer 75(11): 2737-2741
Vassilopoulou-Sellin, R.; Sella, A. 1993: Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(8): 1626
Zhu, X.; Suen, K.L.; Barbacid, M.; Bolen, J.B.; Fargnoli, J. 1994: Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. Journal of Biological Chemistry 269(8): 5518-5522
Burns, L.A.; Karnitz, L.M.; Sutor, S.L.; Abraham, R.T. 1993: Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. Journal of Biological Chemistry 268(24): 17659-17661
Brenner, B.G.; Gornitsky, M.; Wainberg, M.A. 1994: Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS. Clinical and Diagnostic Laboratory Immunology 1(5): 538-544
Matsushita, K.; Arima, N.; Fujiyoshi, T.; Daitoku, Y.; Hidaka, S.; Ohtsubo, H.; Fukumori, J.; Fujiwara, H.; Matsumoto, T.; Tanaka, H. 1996: Interleukin-2-mediated growth of leukemic cells in lymph nodes of patients with adult T-cell leukemia/lymphoma. Leukemia Research 20(2): 135-141
Kopantzev, E.; Roschke, V.; Rudikoff, S. 1998: Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Human Gene Therapy 9(1): 13-19
Dubinett, S.M.; Patrone, L.; Huang, M.; Markowitz, J.; McBride, W.H.; Economou, J.S.; Tobias, J.; Kelley, D.; Yan, D.; Seelig, M. 1993: Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy. Immunological Investigations 22(1): 13-23
Kim, T.S.; Cohen, E.P. 1994: Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma. Cancer Research 54(10): 2531-2535
Sun, T.; Kim, T.S.; Waltz, M.R.; Cohen, E.P. 1995: Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice. Cancer Gene Therapy 2(3): 183-190
Treisman, J.; Hwu, P.; Minamoto, S.; Shafer, G.E.; Cowherd, R.; Morgan, R.A.; Rosenberg, S.A. 1995: Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 85(1): 139-145
Bernsen, M.R.; Van Der Velden, A.W.; Everse, L.A.; Dullens, H.F.; Den Otter, W.; Heintz, A.P. 1998: Interleukin-2: Hope in cases of cisplatin-resistant tumours. Cancer Immunology Immunotherapy: Cii 46(1): 41-47
Oppenheim, M.H.; Lotze, M.T. 1994: Interleukin-2: solid-tumor therapy. Oncology 51(2): 154-169
Bukowski, R.M.; McLain, D.; Olencki, T.; Budd, G.T.; Murthy, S.A. 1993: Interleukin-2: use in solid tumors. Stem Cells 11(1): 26-32
Hara, T.; Ichihara, M.; Takagi, M.; Miyajima, A. 1995: Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85(9): 2331-2336
Shiiba, M.; Takaki, S.; Takatsu, K. 1996: Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor. International Archives of Allergy and Immunology 111(Suppl): 12-15
Krosl, J.; Damen, J.E.; Krystal, G.; Humphries, R.K. 1996: Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit. Journal of Biological Chemistry 271(44): 27432-27437
van Gils, F.C.; Budel, L.M.; Burger, H.; van Leen, R.W.; Löwenberg, B.; Wagemaker, G. 1994: Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. Experimental Hematology 22(3): 248-255
Tsubokawa, M.; Tohyama, Y.; Tohyama, K.; Asahi, M.; Inazu, T.; Nakamura, H.; Saito, H.; Yamamura, H. 1997: Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML193. European Journal of Biochemistry 249(3): 792-796
Khwaja, A.; Addison, I.E.; Johnson, B.; Yong, K.; Linch, D.C. 1994: Interleukin-3 administration enhances human monocyte function in vivo. British Journal of Haematology 88(3): 515-519
Ascaso, R.; Marvel, J.; Collins, M.K.; López-Rivas, A. 1994: Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. European Journal of Immunology 24(3): 537-541
Shibayama, H.; Anzai, N.; Ritchie, A.; Zhang, S.; Mantel, C.; Broxmeyer, H.E. 1998: Interleukin-3 and Flt3-ligand induce adhesion of Baf3/Flt3 precursor B-lymphoid cells to fibronectin via activation of VLA-4 and VLA-5. Cellular Immunology 187(1): 27-33
Mui, A.L.; Miyajima, A. 1994: Interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor signal transduction. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 206(3): 284-288
Zhao, M.L.; Xia, J.Q.; Fritz, R.B. 1993: Interleukin-3 and encephalitogenic activity of SJL/J myelin basic protein-specific T cell lines. Journal of Neuroimmunology 43(1-2): 69-78
Ahlers, A.; Engel, K.; Sott, C.; Gaestel, M.; Herrmann, F.; Brach, M.A. 1994: Interleukin-3 and granulocyte-macrophage colony-stimulating factor induce activation of the MAPKAP kinase 2 resulting in in vitro serine phosphorylation of the small heat shock protein (Hsp 27). Blood 83(7): 1791-1798
Weber, M.M.; Michl, P.; Auernhammer, C.J.; Engelhardt, D. 1997: Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells. Endocrinology 138(5): 2207-2210
Winkler, T.H.; Melchers, F.; Rolink, A.G. 1995: Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood 85(8): 2045-2051
Silva, Z.Z.; Furlanetto, M.P.; Marques, E.K.; Nardi, N.B. 1994: Interleukin-3 and lipopolysaccharide interact to inhibit proliferation of mouse bone marrow cells. Immunology Letters 40(1): 55-58
Caux, C.; Vanbervliet, B.; Massacrier, C.; Durand, I.; Banchereau, J. 1996: Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood 87(6): 2376-2385
Davies, K.; TePas, E.C.; Nathan, D.G.; Mathey-Prevot, B. 1993: Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. Blood 81(4): 928-934
Berridge, M.V.; Tan, A.S. 1995: Interleukin-3 facilitates glucose transport in a myeloid cell line by regulating the affinity of the glucose transporter for glucose: involvement of protein phosphorylation in transporter activation. Biochemical Journal 305: 843-851
Peng, R.; Wang, D.; Xiong, C.; Gao, Y.; Li, Y.; Yang, H.; Cui, Y. 1998: Interleukin-3 gene expression in irradiated mouse bone marrow. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 17(2): 135-139
Fishman, P.; Kamashta, M.; Ehrenfeld, M.; Vianna, J.; Hughes, G.R.; Sredni, D.; Zigelman, R.; Sabo, G.; Shoenfeld, Y. 1993: Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. International Archives of Allergy and Immunology 100(3): 215-218
Woolley, K.L.; Adelroth, E.; Woolley, M.J.; Ramis, I.; Abrams, J.S.; Jordana, M.; O'Byrne, P.M. 1996: Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma. American Journal of Respiratory and Critical Care Medicine 153(1): 350-355
McBride, W.H.; Dougherty, G.D.; Wallis, A.E.; Economou, J.S.; Chiang, C.S. 1994: Interleukin-3 in gene therapy of cancer. Folia Biologica 40(1-2): 62-73
Aglietta, M.; Sanavio, F.; Stacchini, A.; Morelli, S.; Fubini, L.; Severino, A.; Pasquino, P.; Volta, C.; Bretti, S.; Tafuto, S. 1993: Interleukin-3 in vivo: kinetic of response of target cells. Blood 82(7): 2054-2061
Craddock, B.L.; Welham, M.J. 1997: Interleukin-3 induces association of the protein-tyrosine phosphatase SHP2 and phosphatidylinositol 3-kinase with a 100-kDa tyrosine-phosphorylated protein in hemopoietic cells. Journal of Biological Chemistry 272(46): 29281-29289
Liu, L.; Damen, J.E.; Ware, M.D.; Krystal, G. 1997: Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. Journal of Biological Chemistry 272(17): 10998-11001
Rao, P.; Mufson, R.A. 1993: Interleukin-3 inhibits cycloheximide induction of C-jun mRNA in human monocytes: possible role for a serine/threonine phosphatase. Journal of Cellular Physiology 156(3): 560-566
McAdam, A.J.; Yeh, K.Y.; Pulaski, B.A.; Frelinger, J.G.; Lord, E.M. 1993: Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 14(4): 293-297
Chen, Y.Z.; Gu, X.F.; Caen, J.P.; Han, Z.C. 1994: Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells. British Journal of Haematology 88(3): 481-487
Hirsch, H.H.; Nair, A.P.; Backenstoss, V.; Moroni, C. 1995: Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements. Journal of Biological Chemistry 270(35): 20629-20635
Mason-Garcia, M.; Harlan, R.E.; Mallia, C.; Jeter, J.R.; Steinberg, H.B.; Fermin, C.; Beckman, B.S. 1995: Interleukin-3 or erythropoietin induced nuclear localization of protein kinase C beta isoforms in hematopoietic target cells. Cell Proliferation 28(3): 145-155
Cuneo, A.; Balsamo, R.; Roberti, M.G.; Bardi, A.; Piva, N.; Balboni, M.; Bigoni, R.; Rigolin, G.M.; Castoldi, G. 1996: Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients. Cancer Genetics and Cytogenetics 90(2): 171-175
Gerhartz, H.H.; Zwierzina, H.H.; Walther, J.; Fenaux, P.; Hayat, M.; Jacobs, A.; Hoffbrand, A.V.; Dardenne, M.; Solbu, G.; Suciu, S. 1996: Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia: a pilot study. EORTC Leukemia Group. Cancer Investigation 14(4): 299-306
Tafuri, A.; de Felice, L.; Goodacre, A.; Fenu, S.; Petrucci, M.T.; Valentini, T.; Alimena, G.; Petti, M.C.; Meloni, G.; Mandelli, F. 1995: Interleukin-3 priming in acute myeloid leukaemia patients. British Journal of Haematology 91(1): 234-244
Murakami, M.; Austen, K.F.; Bingham, C.O.; Friend, D.S.; Penrose, J.F.; Arm, J.P. 1995: Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells. Journal of Biological Chemistry 270(39): 22653-22656
Azam, M.; Erdjument-Bromage, H.; Kreider, B.L.; Xia, M.; Quelle, F.; Basu, R.; Saris, C.; Tempst, P.; Ihle, J.N.; Schindler, C. 1995: Interleukin-3 signals through multiple isoforms of Stat5. EMBO Journal 14(7): 1402-1411
van Gils, F.C.; van Teeffelen, M.E.; Neelis, K.J.; Hendrikx, J.; Burger, H.; van Leen, R.W.; Knol, E.; Wagemaker, G.; Wognum, A.W. 1995: Interleukin-3 treatment of rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels. Blood 86(2): 592-597
Pallard, C.; Gouilleux, F.; Charon, M.; Groner, B.; Gisselbrecht, S.; Dusanter-Fourt, I. 1995: Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. Journal of Biological Chemistry 270(27): 15942-15945
Mui, A.L.; Wakao, H.; O'Farrell, A.M.; Harada, N.; Miyajima, A. 1995: Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO Journal 14(6): 1166-1175
Mui, A.L.; Wakao, H.; Harada, N.; O'Farrell, A.M.; Miyajima, A. 1995: Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. Journal of Leukocyte Biology 57(5): 799-803
Meister, B.; Herold, M.; Mayr, A.; Widschwendter, M.; Maurer, H.; Heim, K.; Sperl, W. 1993: Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonates. European Journal of Pediatrics 152(7): 569-573
Nakamura, M.; Kirito, K.; Tsunoda, A.; Hara, K.; Furukawa, Y.; Saito, M. 1996: Interleukin-3-associated ganglioside GD1a is induced independently of normal interleukin-3 receptor in murine myelogenous leukaemia NFS60 cells transfected with the interleukin-3 gene. Glycoconjugate Journal 13(2): 255-261
Callus, B.A.; Mathey-Prevot, B. 1998: Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood 91(9): 3182-3192
del Peso, L.; González-García, M.; Page, C.; Herrera, R.; Nuñez, G. 1997: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278(5338): 687-689
Hartnell, A.; Kay, A.B.; Wardlaw, A.J. 1992: Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. Immunology 77(4): 488-493
Speirs, V.; Birch, M.A.; Boyle-Walsh, E.; Green, A.R.; Gallagher, J.A.; White, M.C. 1995: Interleukin-3: A putative protective factor against breast cancer which is secreted by male but not female breast fibroblasts. International Journal of Cancer 61(3): 416-419
Schnyder, B.; Lugli, S.; Feng, N.; Etter, H.; Lutz, R.A.; Ryffel, B.; Sugamura, K.; Wunderli-Allenspach, H.; Moser, R. 1996: Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 87(10): 4286-4295
Niggemann, B.; Zuberbier, T.; Herz, U.; Enssle, K.; Wahn, U.; Renz, H. 1997: Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo. Mediators of Inflammation 6(2): 111-118
Carlsson, M.; Söderberg, O.; Nilsson, K. 1993: Interleukin-4 (IL-4) enhances homotypic adhesion of activated B-chronic lymphocytic leukaemia (B-CLL) cells via a selective up-regulation of CD54. Scandinavian Journal of Immunology 37(4): 515-522
Neben, S.; Donaldson, D.; Fitz, L.; Calvetti, J.; Neben, T.; Turner, K.; Hirayama, F.; Ogawa, M. 1996: Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development. Experimental Hematology 24(7): 783-789
Izuhara, K.; Harada, N. 1993: Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of phosphatidylinositol 3-kinase to the IL-4 receptor in a mouse T cell line, HT2. Journal of Biological Chemistry 268(18): 13097-13102
Dokter, W.H.; Borger, P.; Hendriks, D.; van der Horst, I.; Halie, M.R.; Vellenga, E. 1992: Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level. Blood 80(11): 2721-2728
Izuhara, K.; Harada, N. 1996: Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells. Biochemical and Biophysical Research Communications 229(2): 624-629
Kikuchi, H.; Hanazawa, S.; Takeshita, A.; Nakada, Y.; Yamashita, Y.; Kitano, S. 1994: Interleukin-4 acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages. Biochemical and Biophysical Research Communications 203(1): 562-569
Faber, C.; Sandt, G.; Dang, P.T.; Matgé, G.; Schiltz, F.; Heuschling, P. 1994: Interleukin-4 affects phenotype and proliferative response of peripheral blood lymphocytes from glioblastoma patients after specific or nonspecific in vitro stimulation. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 15(2): 113-118
Tonnetti, L.; Spaccapelo, R.; Cenci, E.; Mencacci, A.; Puccetti, P.; Coffman, R.L.; Bistoni, F.; Romani, L. 1995: Interleukin-4 and -10 exacerbate candidiasis in mice. European Journal of Immunology 25(6): 1559-1565
Heydeck, D.; Thomas, L.; Schnurr, K.; Trebus, F.; Thierfelder, W.E.; Ihle, J.N.; Kühn, H. 1998: Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood 92(7): 2503-2510
Mijatovic, T.; Kruys, V.; Caput, D.; Defrance, P.; Huez, G. 1997: Interleukin-4 and -13 inhibit tumor necrosis factor-alpha mRNA translational activation in lipopolysaccharide-induced mouse macrophages. Journal of Biological Chemistry 272(22): 14394-14398
Awatsuji, H.; Furukawa, Y.; Hirota, M.; Murakami, Y.; Nii, S.; Furukawa, S.; Hayashi, K. 1993: Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. Journal of Neuroscience Research 34(5): 539-545
Fujishima, H.; Shimazaki, J.; Takeuchi, T.; Saito, I.; Tsubota, K. 1996: Interleukin-4 and IgE in seasonal allergic conjunctivitis. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 210(6): 325-328
Sempowski, G.D.; Derdak, S.; Phipps, R.P. 1996: Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. Journal of Cellular Physiology 167(2): 290-296
Kurtzhals, J.A.; Kemp, M.; Poulsen, L.K.; Hansen, M.B.; Kharazmi, A.; Theander, T.G. 1995: Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals. Scandinavian Journal of Immunology 41(4): 343-349
André, F.; Pène, J.; André, C. 1996: Interleukin-4 and interferon-gamma production by peripheral blood mononuclear cells from food-allergic patients. Allergy 51(5): 350-355
Tang, M.L.; Coleman, J.; Kemp, A.S. 1995: Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 25(6): 515-521
Jorgensen, C.; Apparailly, F.; Couret, I.; Canovas, F.; Jacquet, C.; Sany, J. 1998: Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 93(4): 518-523
Zünd, G.; Madara, J.L.; Dzus, A.L.; Awtrey, C.S.; Colgan, S.P. 1996: Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. Journal of Biological Chemistry 271(13): 7460-7464
Blais, Y.; Gingras, S.; Haagensen, D.E.; Labrie, F.; Simard, J. 1996: Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Molecular and Cellular Endocrinology 121(1): 11-18
Jung, T.; Schauer, U.; Rieger, C.; Wagner, K.; Einsle, K.; Neumann, C.; Heusser, C. 1995: Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. European Journal of Immunology 25(8): 2413-2416
Devos, R.; Plaetinck, G.; Cornelis, S.; Guisez, Y.; Van der Heyden, J.; Tavernier, J. 1995: Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease. Journal of Leukocyte Biology 57(6): 813-819
Daher, S.; Santos, L.M.; Solé, D.; De Lima, M.G.; Naspitz, C.K.; Musatti, C.C. 1995: Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children. Journal of Investigational Allergology and Clinical Immunology 5(5): 251-254
Rowe, A.; Bunker, C.B. 1998: Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Dermatitis 38(1): 36-39
Riancho, J.A.; González-Marcías, J.; Amado, J.A.; Olmos, J.M.; Fernández-Luna, J.L. 1995: Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells. Journal of Endocrinological Investigation 18(3): 174-179
Khirwadkar, K.; Zilow, G.; Oppermann, M.; Kabelitz, D.; Rother, K. 1993: Interleukin-4 augments production of the third complement component by the alveolar epithelial cell line A549. International Archives of Allergy and Immunology 100(1): 35-41
Cawston, T.E.; Ellis, A.J.; Bigg, H.; Curry, V.; Lean, E.; Ward, D. 1996: Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines. Biochimica Et Biophysica Acta 1314(3): 226-232
Lissoni, P.; Merlini, D.; Pirato, D.; Meregalli, S. 1997: Interleukin-4 blood concentrations in early and metastatic human solid neoplasms. International Journal of Biological Markers 12(2): 75-78
Dechanet, J.; Taupin, J.L.; Chomarat, P.; Rissoan, M.C.; Moreau, J.F.; Banchereau, J.; Miossec, P. 1994: Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. European Journal of Immunology 24(12): 3222-3228
Steinmann, J.; Herwartz, C.; Müller-Ruchholtz, W. 1993: Interleukin-4 bypass of the immunosuppressive effect mediated by interleukin-2 receptor antibodies. Scandinavian Journal of Immunology 37(2): 217-225
Moran, T.M.; Isobe, H.; Fernandez-Sesma, A.; Schulman, J.L. 1996: Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. Journal of Virology 70(8): 5230-5235
Wang, B.; Gonzalez, A.; Höglund, P.; Katz, J.D.; Benoist, C.; Mathis, D. 1998: Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47(8): 1207-1211
Kitching, A.R.; Tipping, P.G.; Mutch, D.A.; Huang, X.R.; Holdsworth, S.R. 1998: Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney International 53(1): 112-118
Robinet, E.; Kamoun, M.; Farace, F.; Chouaib, S. 1992: Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors. European Journal of Immunology 22(11): 2861-2865
Estes, M.L.; Iwasaki, K.; Jacobs, B.S.; Barna, B.P. 1993: Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation. American Journal of Pathology 143(2): 337-341
Ueno, K.; Katayama, T.; Miyamoto, T.; Koshihara, Y. 1992: Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. Biochemical and Biophysical Research Communications 189(3): 1521-1526
Noble, A.; Kemeny, D.M. 1995: Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells. Immunology 85(3): 357-363
Gibbons, R.; Ross, F.P.; Perkins, S.L.; Lacey, D.L.; Martin, J.; Ebner, R.; Teitelbaum, S.L.; Kahn, A.J. 1994: Interleukin-4 enhances murine bone marrow macrophage M-CSF receptor expression by a posttranscriptional mechanism. Lymphokine and Cytokine Research 13(2): 85-92
Jain-Vora, S.; LeVine, A.M.; Chroneos, Z.; Ross, G.F.; Hull, W.M.; Whitsett, J.A. 1998: Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa. Infection and Immunity 66(9): 4229-4236
Mitchell, P.L.; Clutterbuck, R.D.; Powles, R.L.; De Lord, C.; Morilla, R.; Hiorns, L.R.; Titley, J.; Catovsky, D.; Millar, J.L. 1996: Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia. Blood 87(11): 4797-4803
Borger, P.; Kauffman, H.F.; Postma, D.S.; Vellenga, E. 1996: Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 87(2): 691-698
Gillespie, K.M.; Qasim, F.J.; Tibbatts, L.M.; Thiru, S.; Oliveira, D.B.; Mathieson, P.W. 1995: Interleukin-4 gene expression in mercury-induced autoimmunity. Scandinavian Journal of Immunology 41(3): 268-272
Wery, S.; Letourneur, M.; Bertoglio, J.; Pierre, J. 1996: Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of shc in human keratinocytes. Journal of Biological Chemistry 271(15): 8529-8532
Izuhara, K.; Feldman, R.A.; Greer, P.; Harada, N. 1996: Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. Blood 88(10): 3910-3918
McNally, A.K.; Anderson, J.M. 1995: Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. American Journal of Pathology 147(5): 1487-1499
Toru, H.; Kinashi, T.; Ra, C.; Nonoyama, S.; Yata, J.; Nakahata, T. 1997: Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 89(9): 3296-3302
Clinchy, B.; Möller, G. 1994: Interleukin-4 induces in vitro migration in naive B cells through direct mechanisms. Scandinavian Journal of Immunology 40(4): 429-436
Manabe, A.; Coustan-Smith, E.; Kumagai, M.; Behm, F.G.; Raimondi, S.C.; Pui, C.H.; Campana, D. 1994: Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 83(7): 1731-1737
Suzumura, A.; Sawada, M.; Itoh, Y.; Marunouchi, T. 1994: Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. Journal of Neuroimmunology 53(2): 209-218
Mori, N.; Yamashita, U.; Tanaka, Y.; Nakata, K.; Oda, S.; Morimoto, I.; Eto, S. 1993: Interleukin-4 induces proliferation of adult T-cell leukemia cells. European Journal of Haematology 50(3): 133-140
Moser, R.; Groscurth, P.; Carballido, J.M.; Bruijnzeel, P.L.; Blaser, K.; Heusser, C.H.; Fehr, J. 1993: Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. Journal of Laboratory and Clinical Medicine 122(5): 567-575
Panayiotidis, P.; Ganeshaguru, K.; Jabbar, S.A.; Hoffbrand, A.V. 1993: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. British Journal of Haematology 85(3): 439-445
Bizzarri, C.; Shioi, A.; Teitelbaum, S.L.; Ohara, J.; Harwalkar, V.A.; Erdmann, J.M.; Lacey, D.L.; Civitelli, R. 1994: Interleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts. Journal of Biological Chemistry 269(19): 13817-13824
Miossec, P.; Chomarat, P.; Dechanet, J.; Moreau, J.F.; Roux, J.P.; Delmas, P.; Banchereau, J. 1994: Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis and Rheumatism 37(12): 1715-1722
Vadiveloo, P.K.; Stanton, H.R.; Cochran, F.W.; Hamilton, J.A. 1994: Interleukin-4 inhibits human smooth muscle cell proliferation. Artery 21(3): 161-181
Musso, T.; Gusella, G.L.; Brooks, A.; Longo, D.L.; Varesio, L. 1994: Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 83(5): 1408-1411
Hawker, K.M.; Johnson, P.R.; Hughes, J.M.; Black, J.L. 1998: Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture. American Journal of Physiology 275(3): L469-L477
Hassan, H.T.; Grell, S.; Borrmann-Danso, U.; Freund, M. 1994: Interleukin-4 inhibits proliferation of human leukemic megakaryoblast cell line MHH 225. Hematological Oncology 12(2): 61-66
Sugiyama, E.; Taki, H.; Kuroda, A.; Mino, T.; Yamashita, N.; Kobayashi, M. 1996: Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. Annals of the Rheumatic Diseases 55(6): 375-382
Kawaguchi, H.; Nemoto, K.; Raisz, L.G.; Harrison, J.R.; Voznesensky, O.S.; Alander, C.B.; Pilbeam, C.C. 1996: Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 11(3): 358-366
Nakano, Y.; Watanabe, K.; Morimoto, I.; Okada, Y.; Ura, K.; Sato, K.; Kasono, K.; Nakamura, T.; Eto, S. 1994: Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 9(10): 1533-1539
Nilsson, G.; Miettinen, U.; Ishizaka, T.; Ashman, L.K.; Irani, A.M.; Schwartz, L.B. 1994: Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84(5): 1519-1527
Lee, J.D.; Rhoades, K.; Economou, J.S. 1995: Interleukin-4 inhibits the expression of tumour necrosis factors and alpha and beta, interleukins-1-beta and -6 and interferon-gamma. Immunology and Cell Biology 73(1): 57-61
Kuroda, A.; Sugiyama, E.; Taki, H.; Mino, T.; Kobayashi, M. 1997: Interleukin-4 inhibits the gene expression and biosyntheis of cytosolic phospholipase A2 in lipopolysaccharide stimulated U937 macrophage cell line and freshly prepared adherent rheumatoid synovial cells. Biochemical and Biophysical Research Communications 230(1): 40-43
Dokter, W.H.; Esselink, M.T.; Halie, M.R.; Vellenga, E. 1993: Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes. Blood 81(2): 337-343
Mori, N.; Shirakawa, F.; Murakami, S.; Oda, S.; Eto, S. 1995: Interleukin-4 inhibits the production of interleukin-1 by adult T-cell leukemia cells. European Journal of Haematology 55(2): 121-125
Salerno, A.; Dieli, F.; Sireci, G.; Bellavia, A.; Asherson, G.L. 1995: Interleukin-4 is a critical cytokine in contact sensitivity. Immunology 84(3): 404-409
Santra, S.; Ghosh, S.K. 1997: Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma. Cancer Immunology Immunotherapy: Cii 44(5): 291-300
Coyle, A.J.; Le Gros, G.; Bertrand, C.; Tsuyuki, S.; Heusser, C.H.; Kopf, M.; Anderson, G.P. 1995: Interleukin-4 is required for the induction of lung Th2 mucosal immunity. American Journal of Respiratory Cell and Molecular Biology 13(1): 54-59
Dokter, W.H.; Sierdsema, S.J.; Esselink, M.T.; Halie, M.R.; Vellenga, E. 1994: Interleukin-4 mRNA and protein in activated human T cells are enhanced by interleukin-7. Experimental Hematology 22(1): 74-79
Macon, W.R.; Cousar, J.B.; Waldron, J.A.; Hsu, S.M. 1992: Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas. American Journal of Pathology 141(5): 1031-1036
Sharma, D.P.; Ramsay, A.J.; Maguire, D.J.; Rolph, M.S.; Ramshaw, I.A. 1996: Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. Journal of Virology 70(10): 7103-7107
Goldhill, J.; Morris, S.C.; Maliszewski, C.; Urban, J.F.; Funk, C.D.; Finkelman, F.D.; Shea-Donohue, T. 1997: Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. American Journal of Physiology 272(5 Pt 1): G1135-G1140
Nakazato, Y.; Okada, H.; Tajima, S.; Hayashida, T.; Kanno, Y.; Suzuki, H.; Saruta, T. 1996: Interleukin-4 modulates collagen synthesis by human mesangial cells in a type-specific manner. American Journal of Physiology 270(3 Pt 2): F447-F453
Riancho, J.A.; Zarrabeitia, M.T.; Gonzalez-Macias, J. 1993: Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochemical and Biophysical Research Communications 196(2): 678-685
Brodie, C.; Goldreich, N. 1994: Interleukin-4 modulates the proliferation and differentiation of glial cells. Journal of Neuroimmunology 55(1): 91-97
Smith, D.K.; Korbutt, G.S.; Suarez-Pinzon, W.L.; Kao, D.; Rajotte, R.V.; Elliott, J.F. 1997: Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 64(7): 1040-1049
Hoon, D.S.; Hayashi, Y.; Morisaki, T.; Foshag, L.J.; Morton, D.L. 1993: Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells. Cancer Immunology Immunotherapy: Cii 37(6): 378-384
Szücs, A.; Rubakhin, S.S.; Stefano, G.B.; Hughes, T.K.; Rózsa, K.S. 1995: Interleukin-4 potentiates voltage-activated Ca-currents in Lymnaea neurons. Acta Biologica Hungarica 46(2-4): 351-362
Sawyer, R.G.; Rosenlof, L.K.; Pruett, T.L. 1996: Interleukin-4 prevents mortality from acute but not chronic murine peritonitis and induces an accelerated tumor necrosis factor-alpha response. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 28(2): 119-123
Pu, Q.Q.; Bezwoda, W.R. 1997: Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity. British Journal of Haematology 98(2): 413-417
Sommerlund, M.; Ellermann Eriksen, S.; Haahr, S.; Mogensen, S.C.; Moller Larsen, A. 1994: Interleukin-4 primes human mononuclear phagocytes to an enhanced chemiluminescence response-synergism with interferon-alpha. Immunology and Infectious Diseases 4(2): 106-111
Czuczman, M.S.; Class, K.; Scheinberg, D.A. 1993: Interleukin-4 priming enhances a target for human complement-mediated cytotoxicity of CLL. Leukemia 7(7): 1020-1025
Holter, W.; Kalthoff, F.S.; Majdic, O.; Knapp, W. 1993: Interleukin-4 production by the malignant cell line HUT78. Lymphokine and Cytokine Research 12(1): 33-38
Ohnishi, E.; Iwata, T.; Inouye, S.; Kurata, T.; Sairenji, T. 1997: Interleukin-4 production in Epstein-Barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 17(10): 597-602
Sheikh, S.; Kumar, N.; Zitt, M.; Bouboulis, D.; Wang, S.-Fang; Pahwa, S.; Frieri, M. 1997: Interleukin-4 production in asthmatic patients during allergen immunotherapy: A preliminary study. Pediatric Asthma Allergy and Immunology 11(1): 17-22
Toru, H.; Eguchi, M.; Matsumoto, R.; Yanagida, M.; Yata, J.; Nakahata, T. 1998: Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91(1): 187-195
Santiago, M.L.; Fossati, L.; Jacquet, C.; Müller, W.; Izui, S.; Reininger, L. 1997: Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. Journal of Experimental Medicine 185(1): 65-70
Migliorati, G.; Nicoletti, I.; Pagliacci, M.C.; D'Adamio, L.; Riccardi, C. 1993: Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81(5): 1352-1358
Dello Sbarba, P.; Rovida, E.; Caciagli, B.; Nencioni, L.; Labardi, D.; Paccagnini, A.; Savini, L.; Cipolleschi, M.G. 1996: Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. Journal of Leukocyte Biology 60(5): 644-650
Gavett, S.H.; O'Hearn, D.J.; Karp, C.L.; Patel, E.A.; Schofield, B.H.; Finkelman, F.D.; Wills-Karp, M. 1997: Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. American Journal of Physiology 272(2 Pt 1): L253-L261
Jabara, H.H.; Vercelli, D.; Schneider, L.C.; Williams, D.P.; Genbauffe, F.S.; Poisson, L.R.; Waters, C.A.; Geha, R.S. 1995: Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4. Journal of Allergy and Clinical Immunology 95(4): 893-900
De Wit, H.; Hendriks, D.W.; Halie, M.R.; Vellenga, E. 1994: Interleukin-4 receptor regulation in human monocytic cells. Blood 84(2): 608-615
Debinski, W.; Puri, R.K.; Pastan, I. 1994: Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin. International Journal of Cancer 58(5): 744-748
Defer, M.C.; Dugas, B.; Paul Eugene, N.; Yamaoka, K.; Kolb, J.P.; Damais, C. 1994: Interleukin-4 regulates nitric oxide production by normal human monocytes. Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie 317(11): 1021-1025
Taylor, N.; Candotti, F.; Smith, S.; Oakes, S.A.; Jahn, T.; Isakov, J.; Puck, J.M.; O'Shea, J.J.; Weinberg, K.; Johnston, J.A. 1997: Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. Journal of Biological Chemistry 272(11): 7314-7319
Lee, C.E.; Yoon, S.R.; Pyun, K.H. 1993: Interleukin-4 signals regulating CD23 gene expression in human B cells: protein kinase C-independent signaling pathways. Cellular Immunology 146(1): 171-185
Kolb, J.P.; Paul-Eugene, N.; Damais, C.; Yamaoka, K.; Drapier, J.C.; Dugas, B. 1994: Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. Journal of Biological Chemistry 269(13): 9811-9816
Wojta, J.; Gallicchio, M.; Zoellner, H.; Filonzi, E.L.; Hamilton, J.A.; McGrath, K. 1993: Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood 81(12): 3285-3292
Zenmyo, M.; Hiraoka, K.; Sasaguri, T.; Komiya, S.; Inoue, A.; Morimatsu, M.; Sasaguri, Y. 1996: Interleukin-4 stimulates rheumatoid synovial fibroblasts to express matrix metalloproteinase-1 (Tissue collagenase) and histamine H1 receptor mRNA. Biochemistry and Molecular Biology International 40(6): 1253-1260
Zhou, Y.; Lin, G.; Baarsch, M.J.; Scamurra, R.W.; Murtaugh, M.P. 1994: Interleukin-4 suppresses inflammatory cytokine gene transcription in porcine macrophages. Journal of Leukocyte Biology 56(4): 507-513
Borghaei, R.C.; Rawlings, P.L.; Mochan, E. 1998: Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis and Rheumatism 41(8): 1398-1406
Bennett, B.L.; Cruz, R.; Lacson, R.G.; Manning, A.M. 1997: Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. Journal of Biological Chemistry 272(15): 10212-10219
Metz, K.; Ezernieks, J.; Sebald, W.; Duschl, A. 1996: Interleukin-4 upregulates the heat shock protein Hsp90alpha and enhances transcription of a reporter gene coupled to a single heat shock element. Febs Letters 385(1-2): 25-28
Bradding, P.; Roberts, J.A.; Britten, K.M.; Montefort, S.; Djukanovic, R.; Mueller, R.; Heusser, C.H.; Howarth, P.H.; Holgate, S.T. 1994: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. American Journal of Respiratory Cell and Molecular Biology 10(5): 471-480
Yeh, L.A.; Augustine, A.J.; Lee, P.; Riviere, L.R.; Sheldon, A. 1995: Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. Journal of Rheumatology 22(9): 1740-1746
Hata, T.; Kawamura, T.; Fujiwaki, R.; Aoki, S.; Hata, K.; Inada, K. 1997: Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood. Gynecologic and Obstetric Investigation 43(3): 155-157
Wright, E.D.; Frenkiel, S.; Al-Ghamdi, K.; Ghaffar, O.; Small, P.; Troutt, T.; Tavernier, J.; Hamid, Q. 1998: Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 118(4): 490-495
Welham, M.J.; Duronio, V.; Schrader, J.W. 1994: Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. Journal of Biological Chemistry 269(8): 5865-5873
Lukacs, N.W.; Strieter, R.M.; Chensue, S.W.; Kunkel, S.L. 1994: Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. American Journal of Respiratory Cell and Molecular Biology 10(5): 526-532
Kotanides, H.; Reich, N.C. 1996: Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. Journal of Biological Chemistry 271(41): 25555-25561
McNally, A.K.; DeFife, K.M.; Anderson, J.M. 1996: Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. American Journal of Pathology 149(3): 975-985
Lai, S.Y.; Molden, J.; Liu, K.D.; Puck, J.M.; White, M.D.; Goldsmith, M.A. 1996: Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO Journal 15(17): 4506-4514
Salmon-Ehr, V.; Gillery, P.; Kalis, B.; Banchereau, J.; Maquart, F.X. 1994: Interleukin-4: from B-lymphocyte to fibroblast. Pathologie-Biologie 42(3): 262-268
Randall, T.D.; Lund, F.E.; Brewer, J.W.; Aldridge, C.; Wall, R.; Corley, R.B. 1993: Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation. Molecular and Cellular Biology 13(7): 3929-3936
Mainou-Fowler, T.; Craig, V.A.; Copplestone, J.A.; Hamon, M.D.; Prentice, A.G. 1994: Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood 84(7): 2297-2304
Sturm, D.; Menzel, J.; Gottstein, B.; Kern, P. 1995: Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infection and Immunity 63(5): 1688-1697
Takatsu, K.; Kariyone, A.; Kouro, T.; Kikuchi, Y.; Hitoshi, Y.; Takaki, S. 1995: Interleukin-5 Receptor and CD5-Positive B Cells. Methods (orlando). 8(1): 45-59
Garrelds, I.M.; De Graaf-in 't Veld, T.; Nahori, M.A.; Vargaftig, B.B.; Gerth van Wijk, R.; Zijlstra, F.J. 1995: Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients. European Journal of Pharmacology 275(3): 295-300
Baumann, M.A.; Paul, C.C. 1997: Interleukin-5 and human B lymphocytes. Methods 11(1): 88-97
Lipscombe, R.J.; Nakhoul, A.M.; Sanderson, C.J.; Coombe, D.R. 1998: Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. Journal of Leukocyte Biology 63(3): 342-350
Minshall, E.M.; Schleimer, R.; Cameron, L.; Minnicozzi, M.; Egan, R.W.; Gutierrez-Ramos, J.C.; Eidelman, D.H.; Hamid, Q. 1998: Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. American Journal of Respiratory and Critical Care Medicine 158(3): 951-957
Lee, J.J.; McGarry, M.P.; Farmer, S.C.; Denzler, K.L.; Larson, K.A.; Carrigan, P.E.; Brenneise, I.E.; Horton, M.A.; Haczku, A.; Gelfand, E.W.; Leikauf, G.D.; Lee, N.A. 1997: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. Journal of Experimental Medicine 185(12): 2143-2156
Nakashima, Y.; Mita, S.; Takatsu, K.; Ogawa, M. 1993: Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice. Cancer Immunology Immunotherapy: Cii 37(4): 227-232
Mu, H.H.; Penny, R.; Sewell, W.A. 1993: Interleukin-5 is necessary for eosinophilia induced by cyclophosphamide in immunized mice. Immunology 79(3): 452-458
Bao, S.; McClure, S.J.; Emery, D.L.; Husband, A.J. 1996: Interleukin-5 mRNA expressed by eosinophils and gamma/delta T cells in parasite-immune sheep. European Journal of Immunology 26(3): 552-556
Samoszuk, M.; Ramzi, E.; Cooper, D.L. 1993: Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. American Journal of Hematology 42(4): 402-404
Satoh, T.; Sun, L.; Li, M.S.; Spry, C.J. 1994: Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome. Immunology 83(2): 308-312
Tanaka, Y.; Delaporte, E.; Dubucquoi, S.; Gounni, A.S.; Porchet, E.; Capron, A.; Capron, M. 1994: Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. Journal of Investigative Dermatology 103(4): 589-592
Lai, C.K.; Ho, A.S.; Chan, C.H.; Tang, J.; Leung, J.C.; Lai, K.N. 1996: Interleukin-5 messenger RNA expression in peripheral blood CD4+ cells in asthma. Journal of Allergy and Clinical Immunology 97(6): 1320-1328
Faccioli, L.H.; Medeiros, A.I.; Malheiro, A.; Pietro, R.C.; Januário, A.; Vargaftig, B.B. 1998: Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammation. Mediators of Inflammation 7(1): 41-47
Van Oosterhout, A.J.; Van Der Poel, A.; Koenderman, L.; Roos, D.; Nijkamp, F.P. 1994: Interleukin-5 potentiates sulfidopeptide leukotriene production by human eosinophils. Mediators of Inflammation 3(1): 53-55
Kaminuma, O.; Mori, A.; Suko, M.; Kikkawa, H.; Ikezawa, K.; Okudaira, H. 1996: Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition. Journal of Pharmacology and Experimental Therapeutics 279(1): 240-246
Zanders, E.D. 1994: Interleukin-5 receptor alpha chain mRNA is down-regulated by transforming growth factor beta 1. European Cytokine Network 5(1): 35-42
Terada, N.; Konno, A.; Fukuda, S.; Yamashita, T.; Abe, T.; Shimada, H.; Yoshimura, K.; Shirotori, K.; Ishikawa, K.; Togawa, K. 1995: Interleukin-5 upregulates intercellular adhesion molecule-1 gene expression in the nasal mucosa in nasal allergy but not in nonallergic rhinitis. International Archives of Allergy and Immunology 106(2): 139-145
Ikeda, Y.; Akiyama, K.; Mita, H.; Shida, T. 1994: Interleukin-5-induced generation of superoxide by eosinophils in asthma. Arerugi 43(9): 1185-1193
Hogan, S.P.; Koskinen, A.; Matthaei, K.I.; Young, I.G.; Foster, P.S. 1998: Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. American Journal of Respiratory and Critical Care Medicine 157(1): 210-218
Salvati, A.L.; Lahm, A.; Paonessa, G.; Ciliberto, G.; Toniatti, C. 1995: Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. Journal of Biological Chemistry 270(20): 12242-12249
Tilg, H.; Trehu, E.; Atkins, M.B.; Dinarello, C.A.; Mier, J.W. 1994: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83(1): 113-118
Eustace, D.; Han, X.; Gooding, R.; Rowbottom, A.; Riches, P.; Heyderman, E. 1993: Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecologic Oncology 50(1): 15-19
Mihara, M.; Moriya, Y.; Kishimoto, T.; Ohsugi, Y. 1995: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. British Journal of Rheumatology 34(4): 321-325
Yamazaki, K.; Yamada, E.; Kanaji, Y.; Shizume, K.; Wang, D.S.; Maruo, N.; Obara, T.; Sato, K. 1996: Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles. Endocrinology 137(11): 4857-4863
Pechumer, H.; Wilhelm, M.; Ziegler-Heitbrock, H.W. 1995: Interleukin-6 (IL-6) levels in febrile children during maximal aplasia after bone marrow transplantation (BMT) are similar to those in children with normal hematopoiesis. Annals of Hematology 70(6): 309-312
Takano, H.; Harigaya, K.; Ishii, G.; Sugaya, Y.; Soeta, S.; Nunoyama, T.; Shirasawa, H.; Shimizu, K.; Tokita, H.; Simizu, B.; Mikata, A.; Sekiya, S. 1996: Interleukin-6 (IL-6) production in carcinoma of the cervix. Archives of Gynecology and Obstetrics 258(1): 25-33
Machelon, V.; Emilie, D.; Lefevre, A.; Nome, F.; Durand-Gasselin, I.; Testart, J. 1994: Interleukin-6 biosynthesis in human preovulatory follicles: some of its potential roles at ovulation. Journal of Clinical Endocrinology and Metabolism 79(2): 633-642
Kishimoto, T.; Akira, S.; Narazaki, M.; Taga, T. 1995: Interleukin-6 family of cytokines and gp130. Blood 86(4): 1243-1254
Lichtenstein, A.; Tu, Y.; Fady, C.; Vescio, R.; Berenson, J. 1995: Interleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology 162(2): 248-255
Nonogaki, K.; Fuller, G.M.; Fuentes, N.L.; Moser, A.H.; Staprans, I.; Grunfeld, C.; Feingold, K.R. 1995: Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136(5): 2143-2149
Harroch, S.; Gothelf, Y.; Watanabe, N.; Revel, M.; Chebath, J. 1993: Interleukin-6 activates and regulates transcription factors of the interferon regulatory factor family in M1 cells. Journal of Biological Chemistry 268(12): 9092-9097
Hogenesch, H.; Snyder, P.W.; Scott-Moncrieff, J.C.; Glickman, L.T.; Felsburg, P.J. 1995: Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: Effect of corticosteroids. Clinical Immunology and Immunopathology 77(1): 107-110
Mateo, R.B.; Reichner, J.S.; Albina, J.E. 1994: Interleukin-6 activity in wounds. American Journal of Physiology 266(6 Pt 2): R1840-R1844
Bianchi, M.; Ferrario, P.; Clavenna, A.; Panerai, A.E. 1997: Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice. Neuroreport 8(7): 1775-1778
Mochizuki, Y.; Okamura, Y.; IIda, H.; Mori, H.; Shimada, K. 1998: Interleukin-6 and "complex" cardiac myxoma. Annals of Thoracic Surgery 66(3): 931-933
Behr, D.; Hernvann, A.; Pouard, P.; Spizzi, I.; Leca, F.; Vouhe, P.; Ekindjian, O. 1995: Interleukin-6 and C-reactive protein during pediatric cardiopulmonary bypass. Clinical Chemistry 41(3): 467-469
Tanner, J.E.; Menezes, J. 1994: Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. Blood 84(11): 3956-3964
Bellomo, R.; Tipping, P.; Boyce, N. 1995: Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 17(4): 457-466
Gogusev, J.; Augusti, M.; Chrétien, Y.; Droz, D. 1993: Interleukin-6 and TNF alpha production in human renal cell carcinoma. Kidney International 44(3): 585-592
Fassbender, K.; Pargger, H.; Müller, W.; Zimmerli, W. 1993: Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Critical Care Medicine 21(8): 1175-1180
Ershler, W.B.; Sun, W.H.; Binkley, N.; Gravenstein, S.; Volk, M.J.; Kamoske, G.; Klopp, R.G.; Roecker, E.B.; Daynes, R.A.; Weindruch, R. 1993: Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine and Cytokine Research 12(4): 225-230
Stephanou, A.; Melino, G.; Knight, R.A.; Annicchiarico-Petruzzelli, M.; Sarlis, N.J.; Finazzi-Agro, A.; Lightman, S.L. 1992: Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells. Neuropeptides 23(1): 45-49
Watkins, K.T.; Dudrick, P.S.; Copeland, E.M.; Souba, W.W. 1994: Interleukin-6 and dexamethasone work coordinately to augment hepatic amino acid transport. Journal of Trauma 36(4): 523-528
Okamoto, M.; Webber, M.M.; Quader, S.; Oyasu, R. 1998: Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea. Prostate 35(4): 255-262
An, E.; Ogata, K.; Kuriya, S.; Nomura, T. 1994: Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Experimental Hematology 22(2): 149-156
Kitano, T.; Mori, M.; Hoashi, S.; Yoshitake, S.; Setoguchi, K.; Iwasaka, H.; Noguchi, T.; Honda, N. 1993: Interleukin-6 and glucocorticosteroid responses to cardiopulmonary bypass. Masui. Japanese Journal of Anesthesiology 42(9): 1297-1301
Suzuki, H.; Okano, A.; Ejima, C.; Konishi, A.; Akiyama, Y.; Ozawa, K.; Asano, S. 1996: Interleukin-6 and granulocyte colony-stimulating factor synergistically increase peripheral blood progenitor cells in myelosuppressive mice. Japanese Journal of Cancer Research: Gann 87(9): 938-944
Beamer, N.B.; Coull, B.M.; Clark, W.M.; Hazel, J.S.; Silberger, J.R. 1995: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Annals of Neurology 37(6): 800-805
Gosset, P.; Malaquin, F.; Delneste, Y.; Wallaert, B.; Capron, A.; Joseph, M.; Tonnel, A.B. 1993: Interleukin-6 and interleukin-1 alpha production is associated with antigen-induced late nasal response. Journal of Allergy and Clinical Immunology 92(6): 878-890
Moutabarrik, A.; Nakanishi, I.; Ishibashi, M. 1994: Interleukin-6 and interleukin-6 receptor are expressed by cultured glomerular epithelial cells. Scandinavian Journal of Immunology 40(2): 181-186
Drucker, I.; Klajman, A.; Revel, M.; Manor, Y.; Ben-Efraim, S.; Novick, D. 1997: Interleukin-6 and interleukin-6 receptor secretion by chronic lymphatic leukaemia and normal B lymphocytes: effect of PMA and PWM. Mediators of Inflammation 6(2): 147-153
Iglesias, M.; Plowman, G.D.; Woodworth, C.D. 1995: Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. American Journal of Pathology 146(4): 944-952
Hummel, M.; Czerlinski, S.; Friedel, N.; Liebenthal, C.; Hasper, D.; von Baehr, R.; Hetzer, R.; Volk, H.D. 1994: Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Critical Care Medicine 22(3): 448-454
Martinez, F.; Thomas, N.M.; Darban, H.; Cox, T.J.; Wood, S.; Watson, R.R. 1993: Interleukin-6 and interleukin-8 production by mononuclear cells of chronic alcoholics during treatment. Alcoholism Clinical and Experimental Research 17(6): 1193-1197
Rus, H.G.; Vlaicu, R.; Niculescu, F. 1996: Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127(2): 263-271
Lotz, M.; Villiger, P.; Hugli, T.; Koziol, J.; Zuraw, B.L. 1994: Interleukin-6 and interstitial cystitis. Journal of Urology 152(3): 869-873
Franchimont, N.; Rydziel, S.; Delany, A.M.; Canalis, E. 1997: Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. Journal of Biological Chemistry 272(18): 12144-12150
Frieling, J.T.; van Deuren, M.; Wijdenes, J.; van Dalen, R.; Bartelink, A.K.; van der Linden, C.J.; Sauerwein, R.W. 1996: Interleukin-6 and its soluble receptor during acute meningococcal infections: effect of plasma or whole blood exchange. Critical Care Medicine 24(11): 1801-1805
Franchimont, N.; Durant, D.; Canalis, E. 1997: Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138(8): 3380-3386
Baatout, S. 1996: Interleukin-6 and megakaryocytopoiesis: An update. Annals of Hematology 73(4): 157-162
Oleszczuk, J.; Wawrzycka, B.; Maj, J.G. 1997: Interleukin-6 and neopterin levels in serum of patients with preterm labour with and without infection. European Journal of Obstetrics Gynecology and Reproductive Biology 74(1): 27-30
Hager, K.; Machein, U.; Krieger, S.; Platt, D.; Seefried, G.; Bauer, J. 1994: Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiology of Aging 15(6): 771-772
Riordan, S.M.; Mciver, C.J.; Wakefield, D.; Thomas, M.C.; Duncombe, V.M.; Bolin, T.D. 1998: Interleukin-6 and small intestinal luminal immunoglobulins. Digestive Diseases and Sciences 43(2): 442-445
Schröder, W.; Gaetje, R.; Baumann, R. 1996: Interleukin-6 and soluble interleukin-6 receptor in peritoneal fluid and serum of patients with endometriosis. Clinical and Experimental Obstetrics and Gynecology 23(1): 10-14
Kotake, S.; Sato, K.; Kim, K.J.; Takahashi, N.; Udagawa, N.; Nakamura, I.; Yamaguchi, A.; Kishimoto, T.; Suda, T.; Kashiwazaki, S. 1996: Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 11(1): 88-95
Schweitzer, D.H.; Oostendorp-van de Ruit, M.; Van der Pluijm, G.; Löwik, C.W.; Papapoulos, S.E. 1995: Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 10(6): 956-962
Liu, F.; Poursine-Laurent, J.; Wu, H.Y.; Link, D.C. 1997: Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90(7): 2583-2590
Päth, G.; Bornstein, S.R.; Ehrhart-Bornstein, M.; Scherbaum, W.A. 1997: Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. Journal of Clinical Endocrinology and Metabolism 82(7): 2343-2349
Paquet, P.; Piérard, G.E. 1996: Interleukin-6 and the skin. International Archives of Allergy and Immunology 109(4): 308-317
Sauty, A.; Pecherstorfer, M.; Zimmer-Roth, I.; Fioroni, P.; Juillerat, L.; Markert, M.; Ludwig, H.; Leuenberger, P.; Burckhardt, P.; Thiebaud, D. 1996: Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 18(2): 133-139
Coceani, F.; Lees, J.; Mancilla, J.; Belizario, J.; Dinarello, C.A. 1993: Interleukin-6 and tumor necrosis factor in cerebrospinal fluid: Changes during pyrogen fever. Brain Research 612(1-2): 165-171
Carrasco, J.; Hernandez, J.; Bluethmann, H.; Hidalgo, J. 1998: Interleukin-6 and tumor necrosis factor-alpha type 1 receptor deficient mice reveal a role of IL-6 and TNF-alpha on brain metallothionein-I and -III regulation. Brain Research. Molecular Brain Research 57(2): 221-234
Bajaj, P.; Lawry, J.; Shenton, G.; Rees, R.C. 1993: Interleukin-6 and tumour necrosis factor alpha synergistically block S-phase cell cycle and upregulate intercellular adhesion molecule-1 expression on MCF7 breast carcinoma cells. Cancer Letters 71(1-3): 143-149
Ameglio, F.; Bonifati, C.; Pietravalle, M.; Fazio, M. 1994: Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology 189(4): 359-363
Van Lente, F.; Kazmierczak, S.C. 1995: Interleukin-6 as a first-look indicator of acute myocardial infarction. Clinical Chemistry 41(8 Part 1): 1189-1190
Maruyama, H.; Harada, A.; Kurokawa, T.; Nonami, T.; Nakao, A.; Takagi, H. 1994: Interleukin-6 as a marker of hepatic metabolism following hepatectomy. Hepato-Gastroenterology 41(3): 222-224
Takano, M.; Itoh, N.; Yayama, K.; Yamano, M.; Ohtani, R.; Okamoto, H. 1993: Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochemical Pharmacology 45(1): 201-206
Okamoto, M.; Lee, C.; Oyasu, R. 1997: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Research 57(1): 141-146
Green, J.; Schotland, S.; Sella, Z.; Kleeman, C.R. 1994: Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells. Journal of Clinical Investigation 93(6): 2340-2350
Johnson, J.L.; Moore, E.E.; Tamura, D.Y.; Zallen, G.; Biffl, W.L.; Silliman, C.C. 1998: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. Journal of Surgical Research 76(1): 91-94
Hansen, M.B.; Svenson, M.; Diamant, M.; Abell, K.; Bendtzen, K. 1995: Interleukin-6 autoantibodies: possible biological and clinical significance. Leukemia 9(7): 1113-1115
Falus, A. 1993: Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines. Immunology 78(2): 193-196
Rizzo, G.; Capponi, A.; Rinaldo, D.; Tedeschi, D.; Arduini, D.; Romanini, C. 1996: Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. American Journal of Obstetrics and Gynecology 175(4 Pt 1): 812-817
Rizzo, G.; Capponi, A.; Vlachopoulou, A.; Angelini, E.; Grassi, C.; Romanini, C. 1998: Interleukin-6 concentrations in cervical secretions in the prediction of intrauterine infection in preterm premature rupture of the membranes. Gynecologic and Obstetric Investigation 46(2): 91-95
Doellner, H.; Arntzen, K.J.; Haereid, P.E.; Aag, S.; Austgulen, R. 1998: Interleukin-6 concentrations in neonates evaluated for sepsis. Journal of Pediatrics 132(2): 295-299
Yoon, B.H.; Romero, R.; Yang, S.H.; Jun, J.K.; Kim, I.O.; Choi, J.H.; Syn, H.C. 1996: Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. American Journal of Obstetrics and Gynecology 174(5): 1433-1440
Poli, V.; Balena, R.; Fattori, E.; Markatos, A.; Yamamoto, M.; Tanaka, H.; Ciliberto, G.; Rodan, G.A.; Costantini, F. 1994: Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO Journal 13(5): 1189-1196
Biffl, W.L.; Moore, E.E.; Moore, F.A.; Barnett, C.C. 1996: Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. Journal of Trauma 40(4): 575-8; Discussion 578-9
García-Martínez, C.; López-Soriano, F.J.; Argilés, J.M. 1994: Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Letters 76(1): 1-4
Rosenbaum, J.T.; Kievit, P.; Han, Y.B.; Park, J.M.; Planck, S.R. 1998: Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. IOVS Investigative Ophthalmology and Visual Science 39(1): 64-69
Holt, I.; Davie, M.W.; Braidman, I.P.; Marshall, M.J. 1994: Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Calcified Tissue International 55(2): 114-119
Emonard, H.; Munaut, C.; Melin, M.; Lortat-Jacob, H.; Grimaud, J.A. 1992: Interleukin-6 does not regulate interstitial collagenase, stromelysin and tissue inhibitor of metalloproteinases synthesis by cultured human fibroblasts. Matrix 12(6): 471-474
Dajani, N.; Idriss, E.; Collins, P.L. 1994: Interleukin-6 does not stimulate rat myometrial contractions in an in vitro model. American Journal of Reproductive Immunology 32(3): 248-254
Huang, Y.; Shinzawa, H.; Togashi, H.; Takahashi, T.; Kuzumaki, T.; Otsu, K.; Ishikawa, K. 1995: Interleukin-6 down-regulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase. Archives of Biochemistry and Biophysics 320(2): 203-209
Citarella, F.; Felici, A.; Brouwer, M.; Wagstaff, J.; Fantoni, A.; Hack, C.E. 1997: Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2). Blood 90(4): 1501-1507
Mathieu, J.; Herodin, F.; Chancerelle, Y.; Grenier, N.; Ballester, B.; Platel, S.; Mestries, J.C.; Kergonou, J.F. 1993: Interleukin-6 effect on hematopoietic restoration in rats exposed to mixed neutron-gamma radiation. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1993(14): 27-28
Stouthard, J.M.; Oude Elferink, R.P.; Sauerwein, H.P. 1996: Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 220(2): 241-245
Kobune, M.; Kohgo, Y.; Kato, J.; Miyazaki, E.; Niitsu, Y. 1994: Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 19(6): 1468-1475
de la Mata, J.; Uy, H.L.; Guise, T.A.; Story, B.; Boyce, B.F.; Mundy, G.R.; Roodman, G.D. 1995: Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. Journal of Clinical Investigation 95(6): 2846-2852
Naz, R.K.; Kaplan, P. 1994: Interleukin-6 enhances the fertilizing capacity of human sperm by increasing capacitation and acrosome reaction. Journal of Andrology 15(3): 228-233
Ryffel, B.; Car, B.D.; Gunn, H.; Roman, D.; Hiestand, P.; Mihatsch, M.J. 1994: Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. American Journal of Pathology 144(5): 927-937
Waiser, J.; Budde, K.; Katalinic, A.; Kuerzdörfer, M.; Riess, R.; Neumayer, H.H. 1997: Interleukin-6 expression after renal transplantation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(4): 753-759
Vargas, S.J.; Naprta, A.; Glaccum, M.; Lee, S.K.; Kalinowski, J.; Lorenzo, J.A. 1996: Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 11(11): 1736-1744
Ghaffar, O.; Lavigne, F.; Kamil, A.; Renzi, P.; Hamid, Q. 1998: Interleukin-6 expression in chronic sinusitis: Colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 118(4): 504-511
Singh, B.; Merchant, P.; Walker, C.R.; Kryworuchko, M.; Diaz-Mitoma, F. 1996: Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis. Pediatric Research 39(6): 976-979
Melani, C.; Mattia, G.F.; Silvani, A.; Carè, A.; Rivoltini, L.; Parmiani, G.; Colombo, M.P. 1993: Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood 81(10): 2744-2749
Scales, W.E.; Chensue, S.W.; Kunkel, S.L. 1992: Interleukin-6 expression in immunologically elicited murine macrophages. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 60(5): 289-296
Chevalier, S.; Fourcin, M.; Robledo, O.; Wijdenes, J.; Pouplard-Barthelaix, A.; Gascan, H. 1996: Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. Journal of Biological Chemistry 271(25): 14764-14772
Okada, K.; Shimizu, Y.; Nambu, S.; Higuchi, K.; Watanabe, A. 1994: Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. Journal of Gastroenterology and Hepatology 9(5): 462-467
Okamoto, M.; Hattori, K.; Oyasu, R. 1997: Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. International Journal of Cancer 72(1): 149-154
Fu, J.; Fang, W.; Zheng, J. 1997: Interleukin-6 functions as an autocrine growth stimulator for a human lung adenocarcinoma cell line PAa. Zhonghua Zhong Liu Za Zhi 19(1): 45-48
Barut, B.; Chauhan, D.; Uchiyama, H.; Anderson, K.C. 1993: Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro. Journal of Clinical Investigation 92(5): 2346-2352
Mendel, I.; Katz, A.; Kozak, N.; Ben-Nun, A.; Revel, M. 1998: Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. European Journal of Immunology 28(5): 1727-1737
Hata, H.; Xiao, H.; Petrucci, M.T.; Woodliff, J.; Chang, R.; Epstein, J. 1993: Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 81(12): 3357-3364
Mihara, K. 1996: Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells. International Journal of Hematology 63(3): 215-226
Van der Poll, T.; Keogh, C.V.; Guirao, X.; Buurman, W.A.; Kopf, M.; Lowry, S.F. 1997: Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. Journal of Infectious Diseases 176(2): 439-444
Oláh, K.S.; Neilson, J.P.; Johnson, P.M. 1995: Interleukin-6 in amniotic fluid obtained at forewater amniotomy compared with hindwater samples in women in spontaneous labour. European Journal of Obstetrics Gynecology and Reproductive Biology 60(1): 65-67
Matsuzono, Y.; Narita, M.; Akutsu, Y.; Togashi, T. 1995: Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Paediatrica 84(8): 879-883
Salmayenli, N.; Genc, S.; Karan, A.; Tascioglu, C.; Guler, K.; Vatansever, S.; Sivas, A. 1998: Interleukin-6 in chronic liver diseases. Medical Science Research 26(3): 207-208
Bertolucci, M.; Perego, C.; De Simoni, M.G. 1997: Interleukin-6 is differently modulated by central opioid receptor subtypes. American Journal of Physiology 273(3 Pt 2): R956-R959
Lim, Y.T.; Schenken, R.S. 1993: Interleukin-6 in experimental endometriosis. Fertility and Sterility 59(4): 912-916
Malaguarnera, M.; Trovato, B.A.; Laurino, A.; Di Fazio, I.; Romeo, M.A.; Motta, M. 1996: Interleukin-6 in hepatitis C cirrhosis. Panminerva Medica 38(4): 207-210
Rudloff, H.E.; SchmalstiegFrank, C.Jr.; Palkowetz, K.H.; Paszkiewicz, E.J.; Goldman, A.S. 1992: Interleukin-6 in human milk. Journal of Reproductive Immunology 23(1): 13-20
Klein, B.; Zhang, X.G.; Lu, Z.Y.; Bataille, R. 1995: Interleukin-6 in human multiple myeloma. Blood 85(4): 863-872
Seiler, W.; Müller, H.; Hiemke, C. 1994: Interleukin-6 in plasma collected with an indwelling cannula reflects local, not systemic, concentrations. Clinical Chemistry 40(9): 1778-1779
Elder, J.T.; Sartor, C.I.; Boman, D.K.; Benrazavi, S.; Fisher, G.J.; Pittelkow, M.R. 1992: Interleukin-6 in psoriasis: expression and mitogenicity studies. Archives of Dermatological Research 284(6): 324-332
van Leeuwen, M.A.; Westra, J.; Limburg, P.C.; van Riel, P.L.; van Rijswijk, M.H. 1995: Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Annals of the Rheumatic Diseases 54(1): 33-38
Tsukamoto, T.; Kumamoto, Y.; Miyao, N.; Masumori, N.; Takahashi, A.; Yanase, M. 1992: Interleukin-6 in renal cell carcinoma. Journal of Urology 148(6): 1778-81; Discussion 1781-2
Matalliotakis, I.; Kiriakou, D.; Fragouli, I.; Sifakis, S.; Eliopoulos, G.; Koumantakis, E. 1998: Interleukin-6 in seminal plasma of fertile and infertile men. Archives of Andrology 41(1): 43-50
Fu, K.; Ma, X.; Zhang, Z.; Pang, X.; Chen, W. 1995: Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. Journal of Orofacial Pain 9(2): 131-137
Sack, U.; Kinne, R.W.; Marx, T.; Heppt, P.; Bender, S.; Emmrich, F. 1993: Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatology International 13(2): 45-51
Martín-Ancel, A.; García-Alix, A.; Pascual-Salcedo, D.; Cabañas, F.; Valcarce, M.; Quero, J. 1997: Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 100(5): 789-794
Salahuddin, A.; Rohr-Kirchgraber, T.; Shekar, R.; West, B.; Loewenstein, J. 1997: Interleukin-6 in the fever and multiorgan crisis of pheochromocytoma. Scandinavian Journal of Infectious Diseases 29(6): 640-642
Ullmann, C.D.; Schlom, J.; Greiner, J.W. 1992: Interleukin-6 increases carcinoembryonic antigen and histocompatibility leukocyte antigen expression on the surface of human colorectal carcinoma cells. Journal of Immunotherapy: Official Journal of the Society for Biological Therapy 12(4): 231-241
Ma, T.; Zhu, X. 1997: Interleukin-6 increases the levels of cyclic GMP and nitrite in rat hippocampal slices. European Journal of Pharmacology 321(3): 343-347
Sterneck, E.; Kaplan, D.R.; Johnson, P.F. 1996: Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. Journal of Neurochemistry 67(4): 1365-1374
Biswas, P.; Delfanti, F.; Bernasconi, S.; Mengozzi, M.; Cota, M.; Polentarutti, N.; Mantovani, A.; Lazzarin, A.; Sozzani, S.; Poli, G. 1998: Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91(1): 258-265
Ohira, H.; Miyata, M.; Kuroda, M.; Takagi, T.; Tojo, J.; Ochiai, H.; Kokubun, M.; Nishimaki, T.; Kasukawa, R.; Obara, K. 1996: Interleukin-6 induces proliferation of rat hepatocytes in vivo. Journal of Hepatology 25(6): 941-947
Ebisui, C.; Tsujinaka, T.; Morimoto, T.; Kan, K.; Iijima, S.; Yano, M.; Kominami, E.; Tanaka, K.; Monden, M. 1995: Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clinical Science 89(4): 431-439
Goodman, M.N. 1994: Interleukin-6 induces skeletal muscle protein breakdown in rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 205(2): 182-185
Neumann, C.; Zehentmaier, G.; Danhauser-Riedl, S.; Emmerich, B.; Hallek, M. 1996: Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. European Journal of Immunology 26(2): 379-384
Joseph, J.; Grun, J.L.; Lublin, F.D.; Knobler, R.L. 1993: Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). Journal of Neuroimmunology 42(1): 47-52
Chauhan, D.; Kharbanda, S.; Ogata, A.; Urashima, M.; Teoh, G.; Robertson, M.; Kufe, D.W.; Anderson, K.C. 1997: Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89(1): 227-234
Hughes, F.J.; Howells, G.L. 1993: Interleukin-6 inhibits bone formation in vitro. Bone and Mineral 21(1): 21-28
Bartalena, L.; Hammond, G.L.; Farsetti, A.; Flink, I.L.; Robbins, J. 1993: Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells. Endocrinology 133(1): 291-296
Green, R.M.; Whiting, J.F.; Rosenbluth, A.B.; Beier, D.; Gollan, J.L. 1994: Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. American Journal of Physiology 267(6 Part 1): G1094-G1100
Li, A.J.; Katafuchi, T.; Oda, S.; Hori, T.; Oomura, Y. 1997: Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Research 748(1-2): 30-38
Shibayama, H.; Tagawa, S.; Hattori, H.; Harigaya, K.; Taga, T.; Machii, T.; Kitani, T. 1996: Interleukin-6 inhibits the chemotaxis of human malignant plasma cell lines. British Journal of Haematology 93(3): 534-541
Blais, Y.; Sugimoto, K.; Carrière, M.C.; Haagensen, D.E.; Labrie, F.; Simard, J. 1995: Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. International Journal of Cancer 62(6): 732-737
Aderka, D.; Maor, Y.; Novick, D.; Engelmann, H.; Kahn, Y.; Levo, Y.; Wallach, D.; Revel, M. 1993: Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. Blood 81(8): 2076-2084
Bielefeldt-Ohmann, H.; Marzo, A.L.; Himbeck, R.P.; Jarnicki, A.G.; Robinson, B.W.; Fitzpatrick, D.R. 1995: Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy. Cancer Immunology Immunotherapy: Cii 40(4): 241-250
Iho, S.; Golub, S.H.; Shau, H. 1993: Interleukin-6 is a mediator of TNF-alpha regulation of LAK cell function. Scandinavian Journal of Immunology 38(2): 137-141
Inagaki, T.; Hoshino, M.; Hayakawa, T.; Ohara, H.; Yamada, T.; Yamada, H.; Iida, M.; Nakazawa, T.; Ogasawara, T.; Uchida, A.; Hasegawa, C.; Miyaji, M.; Takeuchi, T. 1997: Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 14(1): 1-8
Renner, U.; Gloddek, J.; Arzt, E.; Inoue, K.; Stalla, G.K. 1997: Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 105(6): 345-352
Fries, K.M.; Felch, M.E.; Phipps, R.P. 1994: Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. American Journal of Respiratory Cell and Molecular Biology 11(5): 552-560
Makishima, F.; Terada, S.; Mikami, T.; Suzuki, E. 1992: Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity. Cytotechnology 10(1): 15-23
Sati, H.I.; Apperley, J.F.; Greaves, M.; Lawry, J.; Gooding, R.; Russell, R.G.; Croucher, P.I. 1998: Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance. British Journal of Haematology 101(2): 287-295
Hampel, H.; Schoen, D.; Schwarz, M.J.; Kötter, H.U.; Schneider, C.; Sunderland, T.; Dukoff, R.; Levy, J.; Padberg, F.; Stübner, S.; Buch, K.; Müller, N.; Möller, H.J. 1997: Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neuroscience Letters 228(3): 143-146
Huell, M.; Strauss, S.; Volk, B.; Berger, M.; Bauer, J. 1995: Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathologica 89(6): 544-551
Dalrymple, S.A.; Slattery, R.; Aud, D.M.; Krishna, M.; Lucian, L.A.; Murray, R. 1996: Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infection and Immunity 64(8): 3231-3235
Dedera, D.A.; Urashima, M.; Chauhan, D.; Lebrun, D.P.; Bronson, R.T.; Anderson, K.C. 1996: Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. British Journal of Haematology 94(1): 53-61
Plante, M.; Rubin, S.C.; Wong, G.Y.; Federici, M.G.; Finstad, C.L.; Gastl, G.A. 1994: Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 73(7): 1882-1888
Silver, R.M.; Schwinzer, B.; McGregor, J.A. 1993: Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: Preeclampsia, small-for-gestational-age fetus, and premature labor. American Journal of Obstetrics and Gynecology 169(5): 1101-1105
Müller, T.; Blum-Degen, D.; Przuntek, H.; Kuhn, W. 1998: Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. Acta Neurologica Scandinavica 98(2): 142-144
Maimone, D.; Annunziata, P.; Simone, I.L.; Livrea, P.; Guazzi, G.C. 1993: Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neuroimmunology 47(1): 55-61
Ringheim, G.E.; Burgher, K.L.; Heroux, J.A. 1995: Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain. Journal of Neuroimmunology 63(2): 113-123
Gonzalez-Hernandez, J.A.; Bornstein, S.R.; Ehrhart-Bornstein, M.; Späth-Schwalbe, E.; Jirikowski, G.; Scherbaum, W.A. 1994: Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. Journal of Clinical Endocrinology and Metabolism 79(5): 1492-1497
Katsume, A.; Miyai, T.; Suzuki, H.; Moriguchi, Y.; Kawata, H.; Tatsumi, T.; Suematsu, S.; Kishimoto, T.; Ohsugi, Y. 1997: Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice. Clinical Immunology and Immunopathology 82(2): 117-124
Hardin, J.; MacLeod, S.; Grigorieva, I.; Chang, R.; Barlogie, B.; Xiao, H.; Epstein, J. 1994: Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84(9): 3063-3070
Matsuda, S.; Wen, T.C.; Morita, F.; Otsuka, H.; Igase, K.; Yoshimura, H.; Sakanaka, M. 1996: Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neuroscience Letters 204(1-2): 109-112
Saito, K.; Ishikura, H.; Kishimoto, T.; Kawarada, Y.; Yano, T.; Takahashi, T.; Kato, H.; Yoshiki, T. 1998: Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: A possible event in tumor regression. International Journal of Cancer 75(2): 284-289
Bankey, P.E.; Williams, J.G.; Guice, K.S.; Taylor, S.N. 1995: Interleukin-6 production after thermal injury: Evidence for nonmacrophage sources in the lung and liver. Surgery 118(2): 431-8; Discussion 438-9
Francis, G.M.; Krohn, E.G.; Woods, K.V.; Buzaid, A.C.; Grimm, E.A. 1996: Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1. Melanoma Research 6(3): 191-201
Bolin, L.M.; Verity, A.N.; Silver, J.E.; Shooter, E.M.; Abrams, J.S. 1995: Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. Journal of Neurochemistry 64(2): 850-858
Palma, C.; Urbani, F.; Manzini, S. 1995: Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activation. Journal of Neuroimmunology 59(1-2): 155-163
Norris, J.G.; Benveniste, E.N. 1993: Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. Journal of Neuroimmunology 45(1-2): 137-145
Esuvaranathan, K.; Alexandroff, A.B.; Mcintyre, M.; Jackson, A.M.; Prescott, S.; Chisholm, G.D.; James, K. 1995: Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. Journal of Urology 154(2 Pt 1): 572-575
Hope, J.C.; Dearman, R.J.; Debicki, R.J.; Kimber, I.; Hopkins, S.J. 1994: Interleukin-6 production by draining lymph node cells following primary contact sensitisation of mice: relationship to the proliferative response. International Archives of Allergy and Immunology 103(4): 378-383
Chen, C.C.; Chang, K.L.; Huang, J.F.; Huang, J.S.; Tsai, C.C. 1998: Interleukin-6 production by human gingival fibroblasts following stimulation with Actinobacillus actinomycetemcomitans. Kaohsiung Journal of Medical Sciences 14(6): 367-378
Baqui, A.A.M.A.; Meiller, T.F.; Chon, J.J.; Turng, B.F.; Falkler, W.A.Jr 1998: Interleukin-6 production by human monocytes treated with granulocyte-macrophage colony-stimulating factor in the presence of lipopolysaccharide of oral microorganisms. Oral Microbiology and Immunology 13(3): 173-180
Vallejo, J.G.; Baker, C.J.; Edwards, M.S. 1996: Interleukin-6 production by human neonatal monocytes stimulated by type IIi group B streptococci. Journal of Infectious Diseases 174(2): 332-337
Ericson, S.G.; Zhao, Y.; Gao, H.; Miller, K.L.; Gibson, L.F.; Lynch, J.P.; Landreth, K.S. 1998: Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. Blood 91(6): 2099-2107
Iwata, H.; Hayashi, T. 1994: Interleukin-6 production by macrophages from BALB/c mice with a chronic infection of lactic dehydrogenase virus. Jikken Dobutsu. Experimental Animals 43(4): 559-562
Müller, C.; Zielinski, C.C. 1992: Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. Journal of Hepatology 15(3): 372-377
Gorospe, W.C.; Spangelo, B.L. 1993: Interleukin-6 production by rat granulosa cells in vitro: effects of cytokines, follicle-stimulating hormone, and cyclic 3',5'-adenosine monophosphate. Biology of Reproduction 48(3): 538-543
Rott, O.; Tontsch, U.; Fleischer, B.; Cash, E. 1993: Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells. European Journal of Immunology 23(8): 1987-1991
Burger, R.; Wendler, J.; Antoni, K.; Helm, G.; Kalden, J.R.; Gramatzki, M. 1994: Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop. Annals of Hematology 69(1): 25-31
Chen, W.; Havell, E.A.; Gigliotti, F.; Harmsen, A.G. 1993: Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infection and Immunity 61(1): 97-102
Hierholzer, C.; Kalff, J.C.; Omert, L.; Tsukada, K.; Loeffert, J.E.; Watkins, S.C.; Billiar, T.R.; Tweardy, D.J. 1998: Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. American Journal of Physiology 275(3): L611-L621
Okada, N.; Kobayashi, M.; Mugikura, K.; Okamatsu, Y.; Hanazawa, S.; Kitano, S.; Hasegawa, K. 1997: Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. Journal of Periodontal Research 32(7): 559-569
Parikh, A.A.; Moon, M.R.; Kane, C.D.; Salzman, A.L.; Fischer, J.E.; Hasselgren, P.O. 1998: Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response. Journal of Surgical Research 77(1): 40-44
Tosato, G.; Jones, K.; Breinig, M.K.; McWilliams, H.P.; McKnight, J.L. 1993: Interleukin-6 production in posttransplant lymphoproliferative disease. Journal of Clinical Investigation 91(6): 2806-2814
Chang, S.G.; Lee, S.J.; Lee, S.J.; Kimi, J.I.; Jung, J.C.; Kim, J.H.; Hoffman, R.M. 1997: Interleukin-6 production in primary histoculture by normal human kidney and renal tumor tissues. Anticancer Research 17(1a): 113-115
Rampino, T.; Libetta, C.; Palumbo, G.; Memoli, B.; Dal Canton, A. 1994: Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 9(11): 1560-1563
Urashima, M.; Ogata, A.; Chauhan, D.; Vidriales, M.B.; Teoh, G.; Hoshi, Y.; Schlossman, R.L.; DeCaprio, J.A.; Anderson, K.C. 1996: Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 88(6): 2219-2227
Yamada, M.; Hatanaka, H. 1994: Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Research 643(1-2): 173-180
Camargo, C.A.; Madden, J.F.; Gao, W.; Selvan, R.S.; Clavien, P.A. 1997: Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26(6): 1513-1520
Sun, R.X.; Gennaro, C.; Rocco, S.; Gu, Z.J.; Klein, B. 1997: Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity. European Cytokine Network 8(1): 51-56
Kiberd, B.A. 1993: Interleukin-6 receptor blockage ameliorates murine lupus nephritis. Journal of the American Society of Nephrology: Jasn 4(1): 58-61
Brown, R.D.; Gorenc, B.; Gibson, J.; Joshua, D. 1993: Interleukin-6 receptor expression and saturation on the bone marrow cells of patients with multiple myeloma. Leukemia 7(2): 221-225
Ishiyama, T.; Koike, M.; Nakamura, S.; Kakimoto, T.; Akimoto, Y.; Tsuruoka, N. 1996: Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease. Annals of Hematology 73(4): 179-182
van de Loo, F.A.; Kuiper, S.; van Enckevort, F.H.; Arntz, O.J.; van den Berg, W.B. 1997: Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. American Journal of Pathology 151(1): 177-191
Sneed, T.B.; Stanley, D.J.; Young, L.A.; Sanderson, R.D. 1994: Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cellular Immunology 153(2): 456-467
Hobisch, A.; Eder, I.E.; Putz, T.; Horninger, W.; Bartsch, G.; Klocker, H.; Culig, Z. 1998: Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Research 58(20): 4640-4645
Viguerie, N.; Bertrand, V.; Dufresne, M.; Davis, E.; Lefort, S.; Vita, N.; Vaysse, N.; Pradayrol, L.; Bastie, M.J. 1994: Interleukin-6 regulation of CCK/gastrin receptors and amylase secretion in a rat pancreatic acinar cell line (AR4-2J). European Cytokine Network 5(5): 433-440
Kossmann, T.; Hans, V.; Imhof, H.G.; Trentz, O.; Morganti-Kossmann, M.C. 1996: Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Research 713(1-2): 143-152
Kanda, T.; Sakamoto, H.; Mcmanus, B.M.; Sakamaki, T.; Nagai, R.; Suzuki, T.; Kobayashi, I. 1996: Interleukin-6 secreted from human myxoma reduces murine viral myocarditis. Life Sciences 58(20): 1705-1712
Takagi, M.; Egawa, T.; Motomura, T.; Sakuma-Mochizuki, J.; Nishimoto, N.; Kasayama, S.; Hayashi, S.; Koga, M.; Yoshizaki, K.; Yoshioka, T.; Okuyama, A.; Kishimoto, T. 1997: Interleukin-6 secreting phaeochromocytoma associated with clinical markers of inflammation. Clinical Endocrinology 46(4): 507-509
Gitter, B.D.; Regoli, D.; Howbert, J.J.; Glasebrook, A.L.; Waters, D.C. 1994: Interleukin-6 secretion from human astrocytoma cells induced by substance P. Journal of Neuroimmunology 51(1): 101-108
Metzger, S.; Goldschmidt, N.; Barash, V.; Peretz, T.; Drize, O.; Shilyansky, J.; Shiloni, E.; Chajek-Shaul, T. 1997: Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. American Journal of Physiology 273(2 Part 1): E262-E267
Qiu, Z.; Parsons, K.L.; Gruol, D.L. 1995: Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(10): 6688-6699
Scambia, G.; Testa, U.; Panici, P.B.; Martucci, R.; Foti, E.; Petrini, M.; Amoroso, M.; Masciullo, V.; Peschle, C.; Mancuso, S. 1994: Interleukin-6 serum levels in patients with gynecological tumors. International Journal of Cancer 57(3): 318-323
Emile, C.; Fermand, J.P.; Danon, F. 1994: Interleukin-6 serum levels in patients with multiple myeloma. British Journal of Haematology 86(2): 439-440
Wijdenes, J.; Heinrich, P.C.; Müller-Newen, G.; Roche, C.; Gu, Z.J.; Clément, C.; Klein, B. 1995: Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. European Journal of Immunology 25(12): 3474-3481
Tsutamoto, T.; Hisanaga, T.; Wada, A.; Maeda, K.; Ohnishi, M.; Fukai, D.; Mabuchi, N.; Sawaki, M.; Kinoshita, M. 1998: Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. Journal of the American College of Cardiology 31(2): 391-398
Sawada, T.; Koike, K.; Kanda, Y.; Ikegami, H.; Jikihara, H.; Maeda, T.; Osako, Y.; Hirota, K.; Miyake, A. 1995: Interleukin-6 stimulates cell proliferation of rat pituitary clonal cell lines in vitro. Journal of Endocrinological Investigation 18(2): 83-90
Stouthard, J.M.; Levi, M.; Hack, C.E.; Veenhof, C.H.; Romijn, H.A.; Sauerwein, H.P.; van der Poll, T. 1996: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thrombosis and Haemostasis 76(5): 738-742
Blumberg, D.; Hochwald, S.; Brennan, M.F.; Burt, M. 1995: Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes. Metabolism, Clinical and Experimental 44(2): 145-146
Biffl, W.L.; Moore, E.E.; Moore, F.A.; Barnett, C.C.; Silliman, C.C.; Peterson, V.M. 1996: Interleukin-6 stimulates neutrophil production of platelet-activating factor. Journal of Leukocyte Biology 59(4): 569-574
Späth-Schwalbe, E.; Born, J.; Schrezenmeier, H.; Bornstein, S.R.; Stromeyer, P.; Drechsler, S.; Fehm, H.L.; Porzsolt, F. 1994: Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. Journal of Clinical Endocrinology and Metabolism 79(4): 1212-1214
Biffl, W.L.; Moore, E.E.; Moore, F.A.; Barnett, C.C. 1995: Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. Journal of Leukocyte Biology 58(5): 582-584
Kozawa, O.; Suzuki, A.; Tokuda, H.; Kaida, T.; Uematsu, T. 1998: Interleukin-6 synthesis induced by prostaglandin E2: Cross-talk regulation by protein kinase C. Bone 22(4): 355-360
Lu, C.; Kerbel, R.S. 1993: Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. Journal of Cell Biology 120(5): 1281-1288
Haverty, A.A.; Harmey, J.H.; Redmond, H.P.; Bouchier-Hayes, D.J. 1997: Interleukin-6 upregulates GP96 expression in breast cancer. Journal of Surgical Research 69(1): 145-149
Franchimont, N.; Gangji, V.; Durant, D.; Canalis, E. 1997: Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-I in osteoblasts. Endocrinology 138(12): 5248-5255
Söderquist, B.; Sundqvist, K.G.; Jones, I.; Holmberg, H.; Vikerfors, T. 1995: Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with S. aureus septicemia. Scandinavian Journal of Infectious Diseases 27(4): 375-380
Hoyland, J.A.; Freemont, A.J.; Sharpe, P.T. 1994: Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 9(1): 75-80
Pham, S.M.; Yoshida, Y.; Aeba, R.; Hattler, B.G.; Iwaki, Y.; Zeevi, A.; Hardesty, R.L.; Griffith, B.P. 1992: Interleukin-6, a marker of preservation injury in clinical lung transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 11(6): 1017-1024
Brass, E.P.; Vetter, W.H. 1994: Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures. Biochemical Journal 301: 193-197
Butler, T.; Ho, M.; Acharya, G.; Tiwari, M.; Gallati, H. 1993: Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrobial Agents and ChemoTherapy 37(11): 2418-2421
Lesur, O.J.; Mancini, N.M.; Humbert, J.C.; Chabot, F.; Polu, J.M. 1994: Interleukin-6, interferon-gamma, and phospholipid levels in the alveolar lining fluid of human lungs. Profiles in coal worker's pneumoconiosis and idiopathic pulmonary fibrosis. Chest 106(2): 407-413
Oláh, K.S.; Vince, G.S.; Neilson, J.P.; Deniz, G.; Johnson, P.M. 1996: Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. Journal of Reproductive Immunology 32(1): 89-98
Pertosa, G.; Grandaliano, G.; Gesualdo, L.; Ranieri, E.; Monno, R.; Schena, F.P. 1998: Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney International 54(2): 570-579
Hata, T.; Kawamura, T.; Inada, K.; Fujiwaki, R.; Ariyuki, Y.; Hata, K.; Kitao, M. 1996: Interleukin-6, interleukin-8, and granulocyte elastase in newborns with fetal distress. Gynecologic and Obstetric Investigation 42(3): 174-177
Terrazzino, S.; Perego, C.; De Luigi, A.; De Simoni, M.G. 1997: Interleukin-6, tumor necrosis factor and corticosterone induction by central lipopolysaccharide in aged rats. Life Sciences 61(7): 695-701
Meekins, J.W. 1995: Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. British Journal of Obstetrics and Gynaecology 102(10): 842-843
Frommberger, U.H.; Bauer, J.; Haselbauer, P.; Fräulin, A.; Riemann, D.; Berger, M. 1997: Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neuroscience 247(4): 228-233
Atkins, M.B.; Kappler, K.; Mier, J.W.; Isaacs, R.E.; Berkman, E.M. 1995: Interleukin-6-associated anemia: determination of the underlying mechanism. Blood 86(4): 1288-1291
Dalrymple, S.A.; Lucian, L.A.; Slattery, R.; McNeil, T.; Aud, D.M.; Fuchino, S.; Lee, F.; Murray, R. 1995: Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infection and Immunity 63(6): 2262-2268
Hüll, M.; Fiebich, B.L.; Lieb, K.; Strauss, S.; Berger, S.S.; Volk, B.; Bauer, J. 1996: Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options. Neurobiology of Aging 17(5): 795-800
Brown, R.E.; Shah, N.R.; Lobel, J.S.; George, B.A.; Gaylord, H.; Simonich, W.L. 1997: Interleukin-6-associated laboratory parameters and immunohistochemistry in symptomatic stage a and B nodular sclerosing Hodgkin's disease in children. Annals of Clinical and Laboratory Science 27(1): 26-33
Weinhold, B.; Rüther, U. 1997: Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochemical Journal 327: 425-429
Xu, F.H.; Sharma, S.; Gardner, A.; Tu, Y.; Raitano, A.; Sawyers, C.; Lichtenstein, A. 1998: Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 92(1): 241-251
Lütticken, C.; Coffer, P.; Yuan, J.; Schwartz, C.; Caldenhoven, E.; Schindler, C.; Kruijer, W.; Heinrich, P.C.; Horn, F. 1995: Interleukin-6-induced serine phosphorylation of transcription factor APRF: Evidence for a role in interleukin-6 target gene induction. FEBS Letters 360(2): 137-143
Matsuda, T.; Yamanaka, Y.; Hirano, T. 1994: Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochemical and Biophysical Research Communications 200(2): 821-828
Kanno, H.; Yasunaga, Y.; Iuchi, K.; Yamauchi, S.; Tatekawa, T.; Sugiyama, H.; Aozasa, K. 1996: Interleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 75(2): 167-173
Deleo, J.A.; Colburn, R.W.; Nichols, M.; Malhotra, A. 1996: Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 16(9): 695-700
Cantwell, C.A.; Sterneck, E.; Johnson, P.F. 1998: Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1. Molecular and Cellular Biology 18(4): 2108-2117
Heinrich, P.C.; Behrmann, I.; Müller-Newen, G.; Schaper, F.; Graeve, L. 1998: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal 334: 297-314
Sehgal, P.B. 1996: Interleukin-6-type cytokines in vivo: regulated bioavailability. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 213(3): 238-247
Borden, E.C.; Chin, P. 1994: Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. Journal of Laboratory and Clinical Medicine 123(6): 824-829
Bartalena, L.; Brogioni, S.; Grasso, L.; Rago, T.; Vitti, P.; Pinchera, A.; Martino, E. 1994: Interleukin-6: a marker of thyroid-destructive processes?. Journal of Clinical Endocrinology and Metabolism 79(5): 1424-1427
Devlin, R.D.; Bone, H.G.; Roodman, G.D. 1996: Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. Journal of Clinical Endocrinology and Metabolism 81(5): 1893-1897
Buck, C.; Bundschu, J.; Gallati, H.; Bartmann, P.; Pohlandt, F. 1994: Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 93(1): 54-58
Le Moine, O.; Devière, J.; Devaster, J.M.; Crusiaux, A.; Durand, F.; Bernuau, J.; Goldman, M.; Benhamou, J.P. 1994: Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. Journal of Hepatology 20(6): 819-824
Simpson, R.J.; Hammacher, A.; Smith, D.K.; Matthews, J.M.; Ward, L.D. 1997: Interleukin-6: structure-function relationships. Protein Science: a Publication of the Protein Society 6(5): 929-955
Jeannin, P.; Delneste, Y.; Lecoanet-Henchoz, S.; Gretener, D.; Bonnefoy, J.Y. 1998: Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and sCD23. Blood 91(4): 1355-1361
Maeurer, M.J.; Walter, W.; Martin, D.; Zitvogel, L.; Elder, E.; Storkus, W.; Lotze, M.T. 1997: Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scandinavian Journal of Immunology 45(2): 182-192
Elner, V.M.; Elner, S.G.; Standiford, T.J.; Lukacs, N.W.; Strieter, R.M.; Kunkel, S.L. 1996: Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8. Experimental Eye Research 63(3): 297-303
Webb, L.M.; Foxwell, B.M.; Feldmann, M. 1997: Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production. European Journal of Immunology 27(3): 633-640
Bilenker, M.; Roberts, A.I.; Brolin, R.E.; Ebert, E.C. 1995: Interleukin-7 activates intestinal lymphocytes. Digestive Diseases and Sciences 40(8): 1744-1749
Page, T.H.; Lali, F.V.; Foxwell, B.M. 1995: Interleukin-7 activates p56lck and p59fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells. European Journal of Immunology 25(10): 2956-2960
Foxwell, B.M.; Beadling, C.; Guschin, D.; Kerr, I.; Cantrell, D. 1995: Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. European Journal of Immunology 25(11): 3041-3046
Sharma, S.; Wang, J.; Huang, M.; Paul, R.W.; Lee, P.; McBride, W.H.; Economou, J.S.; Roth, M.D.; Kiertscher, S.M.; Dubinett, S.M. 1996: Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Therapy 3(5): 302-313
Möller, P.; Czarnetzki, B.M.; Schadendorf, D. 1995: Interleukin 7 in dermatology. Molecular, immunologic and preclinical aspects. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 46(10): 676-682
Wolowczuk, I.; Delacre, M.; Roye, O.; Giannini, S.L.; Auriault, C. 1997: Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease. Immunology 91(1): 35-44
Crawley, J.B.; Willcocks, J.; Foxwell, B.M. 1996: Interleukin-7 induces T cell proliferation in the absence of Erk/MAP kinase activity. European Journal of Immunology 26(11): 2717-2723
Tantawichien, T.; Young, L.S.; Bermudez, L.E. 1996: Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages. Journal of Infectious Diseases 174(3): 574-582
Schadendorf, D.; Böhm, M.; Möller, P.; Grünewald, T.; Czarnetzki, B.M. 1994: Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells. Journal of Investigative Dermatology 102(6): 838-842
Venkitaraman, A.R.; Cowling, R.J. 1994: Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor. European Journal of Immunology 24(9): 2168-2174
Varas, A.; Vicente, A.; Sacedón, R.; Zapata, A.G. 1998: Interleukin-7 influences the development of thymic dendritic cells. Blood 92(1): 93-100
Lee, S.H.; Fujita, N.; Mashima, T.; Tsuruo, T. 1996: Interleukin-7 inhibits apoptosis of mouse malignant T-lymphoma cells by both suppressing the CPP32-like protease activation and inducing the Bcl-2 expression. Oncogene 13(10): 2131-2139
Plum, J.; De Smedt, M.; Leclercq, G.; Verhasselt, B.; Vandekerckhove, B. 1996: Interleukin-7 is a critical growth factor in early human T-cell development. Blood 88(11): 4239-4245
Costello, R.; Brailly, H.; Mallet, F.; Mawas, C.; Olive, D. 1993: Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules. Immunology 80(3): 451-457
Michaelson, M.D.; Mehler, M.F.; Xu, H.; Gross, R.E.; Kessler, J.A. 1996: Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Developmental Biology 179(1): 251-263
Fratazzi, C.; Carini, C. 1996: Interleukin-7 modulates intracytoplasmatic CD23 production and induces adhesion molecule expression and adhesiveness in activated CD4+CD23+ T cell subsets. Clinical Immunology and Immunopathology 81(3): 261-270
Vollger, L.W.; Uittenbogaart, C.H. 1993: Interleukin-7 promotes the generation of phenotypically mature CD45RA positive human thymocytes in vitro. Cytokine 5(2): 157-168
Bagot, M.; Charue, D.; Boulland, M.L.; Gaulard, P.; Revuz, J.; Schmitt, C.; Wechsler, J. 1996: Interleukin-7 receptor expression in cutaneous T-cell lymphomas. British Journal of Dermatology 135(4): 572-575
Seckinger, P.; Milili, M.; Schiff, C.; Fougereau, M. 1994: Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization. European Journal of Immunology 24(3): 716-722
Hernández-Caselles, T.; Martínez-Esparza, M.; Sancho, D.; Rubio, G.; Aparicio, P. 1995: Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. Human Immunology 43(3): 181-189
Dadmarz, R.; Bockstoce, D.C.; Golub, S.H. 1994: Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation. Lymphokine and Cytokine Research 13(6): 349-357
Van der Plas, D.C.; Smiers, F.; Pouwels, K.; Hoefsloot, L.H.; Löwenberg, B.; Touw, I.P. 1996: Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. Leukemia 10(8): 1317-1325
Yssel, H.; Schneider, P.V.; Lanier, L.L. 1993: Interleukin-7 specifically induces the B7/BB1 antigen on human cord blood and peripheral blood T cells and T cell clones. International Immunology 5(7): 753-759
Gringhuis, S.I.; de Leij, L.F.; Verschuren, E.W.; Borger, P.; Vellenga, E. 1997: Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 90(7): 2690-2700
Schadendorf, D.; Czarnetzki, B.M.; Wittig, B. 1995: Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma. Journal of Molecular Medicine 73(9): 473-477
Takashima, A.; Matsue, H.; Bergstresser, P.R.; Ariizumi, K. 1995: Interleukin-7-dependent interaction of dendritic epidermal T cells with keratinocytes. Journal of Investigative Dermatology 105(1 Suppl): 50s-53s
Muegge, K.; Vila, M.P.; Durum, S.K. 1993: Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 261(5117): 93-95
Verburgh, C.A.; Hart, M.H.; Aarden, L.A.; Swaak, A.J. 1993: Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clinical Rheumatology 12(4): 494-499
Miller, E.J.; Nagao, S.; Carr, F.K.; Noble, J.M.; Cohen, A.B. 1996: Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflammation Research: Official Journal of the European Histamine Research Society . 45(8): 386-392
Green, S.P.; Chuntharapai, A.; Curnutte, J.T. 1996: Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor. Journal of Biological Chemistry 271(41): 25400-25405
Cohen, R.F.; Contrino, J.; Spiro, J.D.; Mann, E.A.; Chen, L.L.; Kreutzer, D.L. 1995: Interleukin-8 expression by head and neck squamous cell carcinoma. Archives of Otolaryngology--Head and Neck Surgery 121(2): 202-209
Sharma, S.A.; Tummuru, M.K.; Miller, G.G.; Blaser, M.J. 1995: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infection and Immunity 63(5): 1681-1687
Ando, T.; Kusugami, K.; Ohsuga, M.; Shinoda, M.; Sakakibara, M.; Saito, H.; Fukatsu, A.; Ichiyama, S.; Ohta, M. 1996: Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. American Journal of Gastroenterology 91(6): 1150-1156
Bacon, K.B.; Flores-Romo, L.; Aubry, J.P.; Wells, T.N.; Power, C.A. 1994: Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. Immunology 82(3): 473-481
Alam, R.; Forsythe, P.A.; Lett-Brown, M.A.; Grant, J.A. 1992: Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor. American Journal of Respiratory Cell and Molecular Biology 7(4): 427-433
Storgaard, M.; Larsen, K.; Blegvad, S.; Nødgaard, H.; Ovesen, T.; Andersen, P.L.; Obel, N. 1997: Interleukin-8 and chemotactic activity of middle ear effusions. Journal of Infectious Diseases 175(2): 474-477
Norrby, K. 1996: Interleukin-8 and de novo mammalian angiogenesis. Cell Proliferation 29(6): 315-323
Donnelly, S.C.; Strieter, R.M.; Kunkel, S.L.; Walz, A.; Robertson, C.R.; Carter, D.C.; Grant, I.S.; Pollok, A.J.; Haslett, C. 1993: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341(8846): 643-647
Benfield, T.L.; van Steenwijk, R.; Nielsen, T.L.; Dichter, J.R.; Lipschik, G.Y.; Jensen, B.N.; Junge, J.; Shelhamer, J.H.; Lundgren, J.D. 1995: Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respiratory Medicine 89(4): 285-290
Sheikha, A.; Aljanadi, M.; Alhomrany, M.; Raziuddin, S. 1995: Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hematologic malignancies. International Journal of Oncology 7(1): 95-99
al-Wabel, A.; al-Knawy, B.; Raziuddin, S. 1995: Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis. Clinical Immunology and Immunopathology 74(3): 231-235
Shimoda, K.; Begum, N.A.; Shibuta, K.; Mori, M.; Bonkovsky, H.L.; Banner, B.F.; Barnard, G.F. 1998: Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 28(1): 108-115
McLaughlan, J.M.; Seth, R.; Vautier, G.; Robins, R.A.; Scott, B.B.; Hawkey, C.J.; Jenkins, D. 1997: Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. Journal of Pathology 181(1): 87-92
Krarup, E.; Vestbo, J.; Benfield, T.L.; Lundgren, J.D. 1997: Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respiratory Medicine 91(5): 317-321
D'Angio, C.T.; Sinkin, R.A.; LoMonaco, M.B.; Finkelstein, J.N. 1995: Interleukin-8 and monocyte chemoattractant protein-1 mRNAs in oxygen-injured rabbit lung. American Journal of Physiology 268(5 Part 1): L826-L831
Kasahara, T.; Oda, T.; Hatake, K.; Akiyama, M.; Mukaida, N.; Matsushima, K. 1998: Interleukin-8 and monocyte chemotactic protein-1 production by a human glioblastoma cell line, T98G in coculture with monocytes: involvement of monocyte-derived interleukin-1alpha. European Cytokine Network 9(1): 47-55
Izzo, R.S.; Witkon, K.; Chen, A.I.; Hadjiyane, C.; Weinstein, M.I.; Pellecchia, C. 1992: Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. American Journal of Gastroenterology 87(10): 1447-1452
Crestani, B.; Seta, N.; Palazzo, E.; Rolland, C.; Venembre, P.; Dehoux, M.; Boutten, A.; Soler, P.; Dombret, M.C.; Kahn, M.F. 1994: Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. American Journal of Respiratory and Critical Care Medicine 150(5 Part 1): 1363-1367
Baggiolini, M.; Loetscher, P.; Moser, B. 1995: Interleukin-8 and the chemokine family. International Journal of Immunopharmacology 17(2): 103-108
Agace, W.W.; Hedges, S.R.; Ceska, M.; Svanborg, C. 1993: Interleukin-8 and the neutrophil response to mucosal gram-negative infection. Journal of Clinical Investigation 92(2): 780-785
Dashti, H.M.; Abul, H.; Behbehani, A.; Hussain, T.; Madda, J.P. 1996: Interleukin-8 and trace element alterations in experimentally induced liver cirrhosis: The influence of zinc, selenium, and allopurinol treatment. Journal of Trace Elements in Experimental Medicine 9(1): 27-40
Szekanecz, Z.; Shah, M.R.; Harlow, L.A.; Pearce, W.H.; Koch, A.E. 1994: Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. the possible role of these cytokines in human aortic aneurysmal blood vessel growth. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 62(3): 134-139
Moser, B.; Dewald, B.; Barella, L.; Schumacher, C.; Baggiolini, M.; Clark-Lewis, I. 1993: Interleukin-8 antagonists generated by N-terminal modification. Journal of Biological Chemistry 268(10): 7125-7128
Reisser, D.; Lejeune, P.; Lagadec, P.; Onier, N.; Dasilva, C.; Lindley, I.; Jeannin, J.F. 1994: Interleukin-8 antitumour effect is associated with a local infiltration but not with a systemic activation of T lymphocytes. Anticancer Research 14(3a): 977-979
Koch, A.E.; Polverini, P.J.; Kunkel, S.L.; Harlow, L.A.; Dipietro, L.A.; Elner, V.M.; Elner, S.G.; Strieter, R.M. 1992: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089): 1798-1801
Ujioka, T.; Matsukawa, A.; Tanaka, N.; Matsuura, K.; Yoshinaga, M.; Okamura, H. 1998: Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit ovulatory process: interleukin-8 induces neutrophil accumulation and activation in ovulation. Biology of Reproduction 58(2): 526-530
Winkler, M.; Fischer, D.C.; Ruck, P.; Marx, T.; Kaiserling, E.; Rath, W. 1997: Interleukin-8 associated increase in the number of neutrophilic granulocytes in the cervical stroma as a basic mechanism of cervical dilatation during parturition at term. Geburtshilfe und Frauenheilkunde 57(5): 300-302
Wigmore, S.J.; Fearon, K.C.; Maingay, J.P.; Lai, P.B.; Ross, J.A. 1997: Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. American Journal of Physiology 273(4): E720-E726
Dean, T.P.; Dai, Y.; Shute, J.K.; Church, M.K.; Warner, J.O. 1993: Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatric Research 34(2): 159-161
Ryan, I.P.; Tseng, J.F.; Schriock, E.D.; Khorram, O.; Landers, D.V.; Taylor, R.N. 1995: Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertility and Sterility 63(4): 929-932
Kettritz, R.; Gaido, M.L.; Haller, H.; Luft, F.C.; Jennette, C.J.; Falk, R.J. 1998: Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney International 53(1): 84-91
Kimata, H.; Lindley, I. 1994: Interleukin-8 differentially modulates interleukin-4- and interleukin-2-induced human B cell growth. European Journal of Immunology 24(12): 3237-3240
Ottonello, L.; Lindley, I.J.; Pastorino, G.; Dapino, P.; Dallegri, F. 1994: Interleukin-8 down-regulates the oxidative burst induced by tumor necrosis factor alpha in neutrophils adherent to fibronectin. European Cytokine Network 5(1): 47-50
Zemel, D.; Krediet, R.T.; Koomen, G.C.; Kortekaas, W.M.; Geertzen, H.G.; ten Berge, R.J. 1994: Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 9(2): 169-174
Nibbering, P.H.; Pos, O.; Stevenhagen, A.; Van Furth, R. 1993: Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infection and Immunity 61(8): 3111-3116
Yakabi, K.; Mimura, H.; Iwabuchi, H.; Ro, S.; Nakamura, T. 1998: Interleukin-8 enhances tetragastrin-stimulated acid secretion in vivo. Digestive Diseases and Sciences 43(10): 2317-2321
Crabtree, J.E.; Wyatt, J.I.; Trejdosiewicz, L.K.; Peichl, P.; Nichols, P.H.; Ramsay, N.; Primrose, J.N.; Lindley, I.J. 1994: Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. Journal of Clinical Pathology 47(1): 61-66
Xaubet, A.; Agustí, C.; Luburich, P.; Barberá, J.A.; Carrión, M.; Ayuso, M.C.; Roca, J.; Rodriguez-Roisin, R. 1998: Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. Respiratory Medicine 92(2): 338-344
Thalmann, G.N.; Dewald, B.; Baggiolini, M.; Studer, U.E. 1997: Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: A potential prognostic factor of tumor recurrence and progression. Journal of Urology 158(4): 1340-1344
Yao, L.; Lowy, F.D.; Berman, J.W. 1996: Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells. Infection and Immunity 64(8): 3407-3409
Takeuchi, K.; Maesako, K.; Yuta, A.; Sakakura, Y. 1994: Interleukin-8 gene expression in middle ear effusions. Annals of Otology Rhinology and Laryngology 103(5 Pt 1): 404-407
Kim, J.M.; Jung, H.C.; Cho, Y.J.; Kim, C.Y. 1995: Interleukin-8 gene expression in the human gastric epithelial cells infected with Helicobacter pylori. Journal of the Korean Society for Microbiology 30(4): 391-402
Kukielka, G.L.; Smith, C.W.; LaRosa, G.J.; Manning, A.M.; Mendoza, L.H.; Daly, T.J.; Hughes, B.J.; Youker, K.A.; Hawkins, H.K.; Michael, L.H.; Rot, A.; Entman, M.L. 1995: Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. Journal of Clinical Investigation 95(1): 89-103
Lejeune, P.; Reisser, D.; Onier, N.; Lagadec, P.; Lindley, I.; Jeannin, J.F. 1994: Interleukin-8 has antitumor effects in the rat which are not associated with polymorphonuclear leukocyte cytotoxicity. Cancer Immunology Immunotherapy: Cii 38(3): 167-170
Wismer, J.M.; McKenzie, R.C.; Sauder, D.N. 1994: Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients. Lymphokine and Cytokine Research 13(1): 21-27
Bornscheuer, E.; Schröder, J.M.; Christophers, E.; Sticherling, M. 1996: Interleukin-8 immunoreactivity in malignant tumours of the skin. Acta Dermato-Venereologica 76(3): 210-213
Foss, H.D.; Herbst, H.; Gottstein, S.; Demel, G.; Araujó, I.; Stein, H. 1996: Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density. American Journal of Pathology 148(4): 1229-1236
Nocker, R.E.; Schoonbrood, D.F.; van de Graaf, E.A.; Hack, C.E.; Lutter, R.; Jansen, H.M.; Out, T.A. 1996: Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 109(2): 183-191
Ogushi, F.; Tani, K.; Maniwa, K.; Ichikawa, W.; Tada, H.; Kawano, T.; Sone, S. 1997: Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis. Journal of Medical Investigation: Jmi 44(1-2): 53-58
López-Cortés, L.F.; Cruz-Ruiz, M.; Gómez-Mateos, J.; Viciana-Fernandez, P.; Martinez-Marcos, F.J.; Pachón, J. 1995: Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. Journal of Infectious Diseases 172(2): 581-584
Nakanishi, I.; Moutabarrik, A.; Okada, N.; Kitamura, E.; Hayashi, A.; Syouji, T.; Namiki, M.; Ishibashi, M.; Zaid, D.; Tsubakihara, Y. 1994: Interleukin-8 in chronic renal failure and dialysis patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 9(10): 1435-1442
Seitz, M.; Dewald, B.; Ceska, M.; Gerber, N.; Baggiolini, M. 1992: Interleukin-8 in inflammatory rheumatic diseases: Synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatology International 12(4): 159-164
Moutabarrik, A.; Nakanishi, I.; Okada, N.; Kitamura, E.; Hayashi, A.; Syouji, T.; Tsubakihara, Y. 1995: Interleukin-8 in patients with glomerulonephritis. JN Journal of Nephrology 8(6): 325-330
Halstensen, A.; Ceska, M.; Brandtzaeg, P.; Redl, H.; Naess, A.; Waage, A. 1993: Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. Journal of Infectious Diseases 167(2): 471-475
Arici, A.; Seli, E.; Senturk, L.M.; Gutierrez, L.S.; Oral, E.; Taylor, H.S. 1998: Interleukin-8 in the human endometrium. Journal of Clinical Endocrinology and Metabolism 83(5): 1783-1787
Stiemer, B.; Buschmann, A.; Bisson, S.; Hensel, K.; Gramm, H.J.; Hopp, H.; Weitzel, H.K. 1997: Interleukin-8 in urine: A new diagnostic parameter for intra-amniotic infection after premature rupture of the membranes. British Journal of Obstetrics and Gynaecology 104(4): 499-502
Kemény, L.; Kenderessy, A.S.; Ocsovszky, I.; Michel, G.; Ruzicka, T.; Dobozy, A. 1995: Interleukin-8 induces HLA-DR expression on cultured human keratinocytes via specific receptors. International Archives of Allergy and Immunology 106(4): 351-356
el Maradny, E.; Kanayama, N.; Halim, A.; Maehara, K.; Sumimoto, K.; Terao, T. 1994: Interleukin-8 induces cervical ripening in rabbits. American Journal of Obstetrics and Gynecology 171(1): 77-83
Gesser, B.; Deleuran, B.; Lund, M.; Vestergård, C.; Lohse, N.; Deleuran, M.; Jensen, S.L.; Pedersen, S.S.; Thestrup-Pedersen, K.; Larsen, C.G. 1995: Interleukin-8 induces its own production in CD4+ T lymphocytes: A process regulated by interleukin 10. Biochemical and Biophysical Research Communications 210(3): 660-669
Dunlevy, J.R.; Couchman, J.R. 1995: Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts. Journal of Cell Science 108: 311-321
Jorens, P.G.; Richman-Eisenstat, J.B.; Housset, B.P.; Graf, P.D.; Ueki, I.F.; Olesch, J.; Nadel, J.A. 1992: Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. American Journal of Physiology 263(6 Part 1): L708-L713
Arici, A.; Seli, E.; Zeyneloglu, H.B.; Senturk, L.M.; Oral, E.; Olive, D.L. 1998: Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. Journal of Clinical Endocrinology and Metabolism 83(4): 1201-1205
Laterveer, L.; Lindley, I.J.; Hamilton, M.S.; Willemze, R.; Fibbe, W.E. 1995: Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 85(8): 2269-2275
Francia di Celle, P.; Mariani, S.; Riera, L.; Stacchini, A.; Reato, G.; Foa, R. 1996: Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87(10): 4382-4389
Wang, J.; Huang, M.; Lee, P.; Komanduri, K.; Sharma, S.; Chen, G.; Dubinett, S.M. 1996: Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 16(1): 53-60
Sehmi, R.; Cromwell, O.; Wardlaw, A.J.; Moqbel, R.; Kay, A.B. 1993: Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 23(12): 1027-1036
Bang, H.; Brune, K.; Nager, C.; Feige, U. 1993: Interleukin-8 is a cyclosporin A binding protein. Experientia 49(6-7): 533-538
Boylan, A.M.; Hébert, C.A.; Sadick, M.; Wong, W.L.; Chuntharapai, A.; Hoeffel, J.M.; Hartiala, K.T.; Broaddus, V.C. 1994: Interleukin-8 is a major component of pleural liquid chemotactic activity in a rabbit model of endotoxin pleurisy. American Journal of Physiology 267(2 Pt 1): L137-L144
Broaddus, V.C.; Hébert, C.A.; Vitangcol, R.V.; Hoeffel, J.M.; Bernstein, M.S.; Boylan, A.M. 1992: Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. American Review of Respiratory Disease 146(4): 825-830
Sennström, M.K.; Brauner, A.; Lu, Y.; Granström, L.M.; Malmström, A.L.; Ekman, G.E. 1997: Interleukin-8 is a mediator of the final cervical ripening in humans. European Journal of Obstetrics Gynecology and Reproductive Biology 74(1): 89-92
Erger, R.A.; Casale, T.B. 1995: Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. American Journal of Physiology 268(1 Part 1): L117-L122
Yue, T.L.; Mckenna, P.J.; Gu, J.L.; Feuerstein, G.Z. 1993: Interleukin-8 is chemotactic for vascular smooth muscle cells. European Journal of Pharmacology 240(1): 81-84
Sakamoto, K.; Masuda, T.; Mita, S.; Ishiko, T.; Nakashima, Y.; Arakawa, H.; Egami, H.; Harada, S.; Matsushima, K.; Ogawa, M. 1992: Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines. International Journal of Clinical and Laboratory Research 22(4): 216-219
Konstantinova, N.V.; Duong, D.M.; Remenyik, E.; Hazarika, P.; Chuang, A.; Duvic, M. 1996: Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. Journal of Investigative Dermatology 107(4): 615-621
Siminiak, T.; Schröder, J.M.; Sticherling, M.; Wysocki, H. 1993: Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction. Basic Research in Cardiology 88(2): 150-154
Shimoya, K.; Matsuzaki, N.; Taniguchi, T.; Okada, T.; Saji, F.; Murata, Y. 1997: Interleukin-8 level in maternal serum as a marker for screening of histological chorioamnionitis at term. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 57(2): 153-159
Segura, R.M.; Alegre, J.; Varela, E.; Marti, R.; Surinach, J.M.; Jufresa, J.; Armadans, L.; Pascual, C.; Fernandez, D.S.villa, T. 1998: Interleukin-8 markers of neutrophil degranulation in pleural effusions. American Journal of Respiratory and Critical Care Medicine 157(5 Part 1): 1565-1572
Yatsunami, J.; Tsuruta, N.; Ogata, K.; Wakamatsu, K.; Takayama, K.; Kawasaki, M.; Nakanishi, Y.; Hara, N.; Hayashi, S.I.hiro 1997: Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Letters 120(1): 101-108,. 25
Erger, R.A.; Casale, T.B. 1998: Interleukin-8 plays a significant role in IgE-mediated lung inflammation. European Respiratory Journal 11(2): 299-305
Wozniak, A.; Betts, W.H.; Murphy, G.A.; Rokicinski, M. 1993: Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 79(4): 608-615
Van Dervort, A.L.; Lam, C.; Culpepper, S.; Tuschil, A.F.; Wesley, R.A.; Danner, R.L. 1998: Interleukin-8 priming of human neutrophils is not associated with persistently altered calcium fluxes but is additive with lipopolysaccharide. Journal of Leukocyte Biology 64(4): 511-518
Padrines, M.; Wolf, M.; Walz, A.; Baggiolini, M. 1994: Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. Febs Letters 352(2): 231-235
Saito, S.; Kasahara, T.; Sakakura, S.; Enomoto, M.; Umekage, H.; Harada, N.; Morii, T.; Nishikawa, K.; Narita, N.; Ichijo, M. 1994: Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Biochemical and Biophysical Research Communications 200(1): 378-383
Black, H.R.; Yankaskas, J.R.; Johnson, L.G.; Noah, T.L. 1998: Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. American Journal of Respiratory Cell and Molecular Biology 19(2): 210-215
Visser, C.E.; Steenbergen, J.J.; Betjes, M.G.; Meijer, S.; Arisz, L.; Hoefsmit, E.C.; Krediet, R.T.; Beelen, R.H. 1995: Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci. Infection and Immunity 63(10): 4206-4209
Krakauer, T. 1998: Interleukin-8 production by human monocytic cells in response to staphylococcal exotoxins is direct and independent of interleukin-1 and tumor necrosis factor-alpha. Journal of Infectious Diseases 178(2): 573-577
Betjes, M.G.; Tuk, C.W.; Struijk, D.G.; Krediet, R.T.; Arisz, L.; Hart, M.; Beelen, R.H. 1993: Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. Journal of Infectious Diseases 168(5): 1202-1210
Apostolopoulos, J.; Davenport, P.; Tipping, P.G. 1996: Interleukin-8 production by macrophages from atheromatous plaques. Arteriosclerosis Thrombosis and Vascular Biology 16(8): 1007-1012
Gainet, J.; Chollet-Martin, S.; Brion, M.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Interleukin-8 production by polymorphonuclear neutrophils in patients with rapidly progressive periodontitis: an amplifying loop of polymorphonuclear neutrophil activation. Laboratory Investigation; a Journal of Technical Methods and Pathology 78(6): 755-762
Barclay, C.G.; Brennand, J.E.; Kelly, R.W.; Calder, A.A. 1993: Interleukin-8 production by the human cervix. American Journal of Obstetrics and Gynecology 169(3): 625-632
Kolios, G.; Robertson, D.A.; Jordan, N.J.; Minty, A.; Caput, D.; Ferrara, P.; Westwick, J. 1996: Interleukin-8 production by the human colon epithelial cell line HT-29: Modulation by interleukin-13. British Journal of Pharmacology 119(2): 351-359
Morita, E.; Yamada, S.; Kimura, I.; Nakamura, K.; Sugita, Y.; Yamamoto, S. 1993: Interleukin-8 production from cultured human dermal fibroblasts by stimulation with supernatant of cultured human epidermal cells. Skin Pharmacology: the Official Journal of the Skin Pharmacology Society 6(3): 161-169
Jorens, P.G.; De Jongh, R.; De Backer, W.; Van Damme, J.; Van Overveld, F.; Bossaert, L.; Walter, P.; Herman, A.G.; Rampart, M. 1993: Interleukin-8 production in patients undergoing cardiopulmonary bypass. the influence of pretreatment with methylprednisolone. American Review of Respiratory Disease 148(4 Part 1): 890-895
Chabot-Fletcher, M.; Breton, J.; Lee, J.; Young, P.; Griswold, D.E. 1994: Interleukin-8 production is regulated by protein kinase C in human keratinocytes. Journal of Investigative Dermatology 103(4): 509-515
Xia, M.; Qin, S.; McNamara, M.; Mackay, C.; Hyman, B.T. 1997: Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. American Journal of Pathology 150(4): 1267-1274
Ben-Baruch, A.; Bengali, K.M.; Biragyn, A.; Johnston, J.J.; Wang, J.M.; Kim, J.; Chuntharapai, A.; Michiel, D.F.; Oppenheim, J.J.; Kelvin, D.J. 1995: Interleukin-8 receptor beta. the role of the carboxyl terminus in signal transduction. Journal of Biological Chemistry 270(16): 9121-9128
Arenberger, P.; Kemény, L.; Süss, R.; Michel, G.; Peter, R.U.; Ruzicka, T. 1992: Interleukin-8 receptors in normal and psoriatic polymorphonuclear leukocytes. Acta Dermato-Venereologica 72(5): 334-336
Knall, C.; Young, S.; Nick, J.A.; Buhl, A.M.; Worthen, G.S.; Johnson, G.L. 1996: Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. Journal of Biological Chemistry 271(5): 2832-2838
Finn, A.; Naik, S.; Klein, N.; Levinsky, R.J.; Strobel, S.; Elliott, M. 1993: Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 105(2): 234-241
Laham, N.; Brennecke, S.P.; Rice, G.E. 1997: Interleukin-8 release from human gestational tissue explants: the effects of lipopolysaccharide and cytokines. Biology of Reproduction 57(3): 616-620
Arnold, R.; König, W. 1998: Interleukin-8 release from human neutrophils after phagocytosis of Listeria monocytogenes and Yersinia enterocolitica. Journal of Medical Microbiology 47(1): 55-62
Redl, H.; Schlag, G.; Ceska, M.; Davies, J.; Buurman, W.A. 1993: Interleukin-8 release in baboon septicemia is partially dependent on tumor necrosis factor. Journal of Infectious Diseases 167(6): 1464-1466
Kossmann, T.; Stahel, P.F.; Lenzlinger, P.M.; Redl, H.; Dubs, R.W.; Trentz, O.; Schlag, G.; Morganti-Kossmann, M.C. 1997: Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 17(3): 280-289
Deleuran, B.; Iversen, L.; Kristensen, M.; Field, M.; Kragballe, K.; Thestrup-Pedersen, K.; Stengaard-Pedersen, K. 1994: Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: in vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein. British Journal of Rheumatology 33(6): 520-525
Gosset, P.; Tillie-Leblond, I.; Malaquin, F.; Durieu, J.; Wallaert, B.; Tonnel, A.B. 1997: Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: Interleukin-8 is not the main chemotactic factor present in nasal lavages. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 27(4): 379-388
Khabar, K.S.; Al-Zoghaibi, F.; Murayama, T.; Matsushima, K.; Mukaida, N.; Siddiqui, Y.; Dhalla, M.; Al-Ahdal, M.N. 1997: Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochemical and Biophysical Research Communications 235(3): 774-778
Hu, D.E.; Hori, Y.; Fan, T.P. 1993: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17(2): 135-143
Fujiwara, Y.; Arakawa, T.; Fukuda, T.; Sasaki, E.; Nakagawa, K.; Fujiwara, K.; Higuchi, K.; Kobayashi, K.; Tarnawski, A. 1997: Interleukin-8 stimulates leukocyte migration across a monolayer of cultured rabbit gastric epithelial cells. Effect associated with the impairment of gastric epithelial barrier function. Digestive Diseases and Sciences 42(6): 1210-1215
Heniford, B.T.; Edwards, M.J.; Wilson, M.A.; Klar, E.A.; Doak, K.W.; Miller, F.N. 1994: Interleukin-8 suppresses the toxicity and antitumor effect of interleukin-2. Journal of Surgical Research 56(1): 82-88
Osmers, R.G.; Bläser, J.; Kuhn, W.; Tschesche, H. 1995: Interleukin-8 synthesis and the onset of labor. Obstetrics and Gynecology 86(2): 223-229
Arnold, R.; Humbert, B.; Werchau, H.; Gallati, H.; König, W. 1994: Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82(1): 126-133
Schratzberger, P.; Dunzendorfer, S.; Reinisch, N.; Kähler, C.M.; Wiedermann, C.J. 1997: Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro. Immunology Letters 58(3): 167-170
Leuenroth, S.; Lee, C.; Grutkoski, P.; Keeping, H.; Simms, H.H. 1998: Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery 124(2): 409-417
Bacon, K.B.; Quinn, D.G.; Aubry, J.P.; Camp, R.D. 1993: Interleukin-8-stimulated polyphosphoinositide hydrolysis in human peripheral blood lymphocytes. Blood 81(2): 430-436
Strieter, R.M.; Kunkel, S.L.; Elner, V.M.; Martonyi, C.L.; Koch, A.E.; Polverini, P.J.; Elner, S.G. 1992: Interleukin-8. A corneal factor that induces neovascularization. American Journal of Pathology 141(6): 1279-1284
Yue, T.L.; Wang, X.; Sung, C.P.; Olson, B.; McKenna, P.J.; Gu, J.L.; Feuerstein, G.Z. 1994: Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circulation Research 75(1): 1-7
Richman-Eisenstat, J.B.; Jorens, P.G.; Hébert, C.A.; Ueki, I.; Nadel, J.A. 1993: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. American Journal of Physiology 264(4 Pt 1): L413-L418
Miller, E.J.; Idell, S. 1993: Interleukin-8: an important neutrophil chemotaxin in some cases of exudative pleural effusions. Experimental Lung Research 19(5): 589-601
Southcott, A.M.; Jones, K.P.; Li, D.; Majumdar, S.; Cambrey, A.D.; Pantelidis, P.; Black, C.M.; Laurent, G.J.; Davies, B.H.; Jeffery, P.K. 1995: Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. American Journal of Respiratory and Critical Care Medicine 151(5): 1604-1612
Yin, T.; Keller, S.R.; Quelle, F.W.; Witthuhn, B.A.; Tsang, M.L.; Lienhard, G.E.; Ihle, J.N.; Yang, Y.C. 1995: Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. Journal of Biological Chemistry 270(35): 20497-20502
Renauld, J.C.; Kermouni, A.; Vink, A.; Louahed, J.; Van Snick, J. 1995: Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. Journal of Leukocyte Biology 57(3): 353-360
Renauld, J.C.; Vink, A.; Louahed, J.; Van Snick, J. 1995: Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85(5): 1300-1305
Petit-Frere, C.; Dugas, B.; Braquet, P.; Mencia-Huerta, J.M. 1993: Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 79(1): 146-151
Dugas, B.; Renauld, J.C.; Pène, J.; Bonnefoy, J.Y.; Peti-Frère, C.; Braquet, P.; Bousquet, J.; Van Snick, J.; Mencia-Huerta, J.M. 1993: Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. European Journal of Immunology 23(7): 1687-1692
Hossain, M.M.; Tsuchie, H.; Detorio, M.A.; Shirono, H.; Hara, C.; Nishimoto, A.; Saji, A.; Koga, J.; Takata, N.; Maniar, J.K.; Saple, D.G.; Taniguchi, K.; Kageyama, S.; Ichimura, H.; Kurimura, T. 1998: Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s). Acta Virologica 42(1): 47-53
Vink, A.; Renauld, J.C.; Warnier, G.; Van Snick, J. 1993: Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas. European Journal of Immunology 23(5): 1134-1138
Schaafsma, M.R.; Falkenburg, J.H.; Duinkerken, N.; Van Snick, J.; Landegent, J.E.; Willemze, R.; Fibbe, W.E. 1993: Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: Additive effect with GM-CSF. Annals of Hematology 66(1): 45-49
Lemoli, R.M.; Fortuna, A.; Tafuri, A.; Fogli, M.; Amabile, M.; Grande, A.; Ricciardi, M.R.; Petrucci, M.T.; Bonsi, L.; Bagnara, G.; Visani, G.; Martinelli, G.; Ferrari, S.; Tura, S. 1996: Interleukin-9 stimulates the proliferation of human myeloid leukemic cells. Blood 87(9): 3852-3859
Tanaka, Y.; Narahara, H.; Takai, N.; Yoshimatsu, J.; Anai, T.; Miyakawa, I. 1998: Interleukin-1beta and interleukin-8 in cervicovaginal fluid during pregnancy. American Journal of Obstetrics and Gynecology 179(3 Pt 1): 644-649
Akyol, G. 1994: Interleukins. Mikrobiyoloji Bulteni 28(3): 286-293
Rashleigh, S.P.; Kusher, D.I.; Endicott, J.N.; Rossi, A.R.; Djeu, J.Y. 1996: Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma. Archives of Otolaryngology--Head and Neck Surgery 122(5): 541-547
Barton, B.E.; Shortall, J.; Jackson, J.V. 1996: Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infection and Immunity 64(3): 714-718
Galanaud, P.; Emilie, D. 1994: Interleukins and HIV disease. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 188(1): 23-30
Hadden, J.W.; Endicott, J.; Baekey, P.; Skipper, P.; Hadden, E.M. 1994: Interleukins and contrasuppression induce immune regression of head and neck cancer. Archives of Otolaryngology--Head and Neck Surgery 120(4): 395-403
Schölmerich, J. 1996: Interleukins in acute pancreatitis. Scandinavian Journal of Gastroenterology. Suppl 219: 37-42
Chebotar'ov, V.F.; Kotlyarenko, N.M. 1995: Interleukins in parenchymatous and nonparenchymatous mouse liver cells under diabetes mellitus. Dopovidi Natsional'noyi Akademiyi Nauk Ukrayiny 1995(11): 145-147
Naz, R.K.; Butler, A. 1996: Interleukins-6 and -8 levels in sera and cervical mucus of fertile, idiopathic infertile, and immunoinfertile women: Implication in infertility. American Journal of Reproductive Immunology 35(6): 534-540
Sherwood, D.E. 1994: Interlimb amplitude differences, spatial assimilations, and the temporal structure of rapid bimanual movements. Human Movement Science 13(6): 841-860
Oda, S.; Moritani, T. 1996: Interlimb co-ordination of force and movement-related cortical potentials. European Journal of Applied Physiology and Occupational Physiology 74(1-2): 8-12
Verschueren, S.M.; Swinnen, S.P.; Dom, R.; De Weerdt, W. 1997: Interlimb coordination in patients with Parkinson's disease: Motor learning deficits and the importance of augmented information feedback. Experimental Brain Research 113(3): 497-508
Shapiro, L.J.; Anapol, F.C.; Jungers, W.L. 1997: Interlimb coordination, gait, and neural control of quadrupedalism in chimpanzees. American Journal of Physical Anthropology 102(2): 177-186
Swinnen, S., P.; Lee, T., D.; Verschueren, S.; Serrien, D., J.; Bogaerds, H. 1997: Interlimb coordination: Learning and transfer under different feedback conditions. Human Movement Science 16(6): 749-785
Sternad, D.; Saltzman, E., L.; Turvey, M.T. 1998: Interlimb coupling in a simple serial behavior: A task dynamic approach. Human Movement Science 17(3): 393-433
Sugden, D.; Utley, A. 1995: Interlimb coupling in children with hemiplegic cerebral palsy. Developmental Medicine and Child Neurology 37(4): 293-309
Utley, A.; Sugden, D. 1998: Interlimb coupling in children with hemiplegic cerebral palsy during reaching and grasping at speed. Developmental Medicine and Child Neurology 40(6): 396-404
Kang, S.W.; Na, Y.M.; Moon, J.H.; Chun, S.I.; Yoon, Y.R. 1997: Interlimb interaction and stabilization of contralateral leg in isokinetic knee evaluation. Archives of Physical Medicine and Rehabilitation 78(5): 497-500
Limper, A.H.; Specks, U.; Brutinel, W.M.; Martin, W.J.; Rohrbach, M.S. 1993: Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers. Journal of Laboratory and Clinical Medicine 121(6): 785-791
Beatty, E.J.; Cox, M.C.; Frenkiel, T.A.; Tam, B.M.; Mason, A.B.; MacGillivray, R.T.; Sadler, P.J.; Woodworth, R.C. 1996: Interlobe communication in 13C-methionine-labeled human transferrin. Biochemistry 35(24): 7635-7642
Mukherjea, P.; Maune, J.F.; Beckingham, K. 1996: Interlobe communication in multiple calcium-binding site mutants of Drosophila calmodulin. Protein Science: a Publication of the Protein Society 5(3): 468-477
Martinoli, C.; Crespi, G.; Bertolotto, M.; Rollandi, G.A.; Rosenberg, I.; Pretolesi, F.; Derchi, L.E. 1996: Interlobular vasculature in renal transplants: a power Doppler US study with MR correlation. Radiology 200(1): 111-117
Winter, A.J.; Alkema, M.J.; Groot Koerkamp, M.J.; van der Horst, G.; Mul, Y.; Tabak, H.F. 1993: Interlocked circle formation by group I introns: structural requirements and mechanism. Nucleic Acids Research 21(14): 3217-3226
Antoszyk, J.H.; Tucker, N.; Ling, C.; Codere, F. 1993: Interlocking Crawford triangles in frontalis suspension. Archives of Ophthalmology 111(6): 875-878
Cekirge, H.S.; Saatci, I.; Firat, M.M.; Balkanci, F.; Besim, A. 1996: Interlocking detachable coil occlusion in the endovascular treatment of intracranial aneurysms: preliminary results. Ajnr. American Journal of Neuroradiology 17(9): 1651-1657
Beaty, J.H.; Austin, S.M.; Warner, W.C.; Canale, S.T.; Nichols, L. 1994: Interlocking intramedullary nailing of femoral-shaft fractures in adolescents: preliminary results and complications. Journal of Pediatric Orthopedics 14(2): 178-183
Redmond, B.J.; Biermann, J.S.; Blasier, R.B. 1996: Interlocking intramedullary nailing of pathological fractures of the shaft of the humerus. Journal of Bone and Joint Surgery. American Volume 78(6): 891-896
Hems, T.E.; Bhullar, T.P. 1996: Interlocking nailing of humeral shaft fractures: The oxford experience 1991 to 1994. Injury 27(7): 485-489
Wu, H.Y.; Lau, K.; Liu, L.F. 1992: Interlocking of plasmid DNAs due to Lac repressor-operator interaction. Journal of Molecular Biology 228(4): 1104-1114
Michelson, S.; Leith, J.T. 1995: Interlocking triads of growth control in tumors. Bulletin of Mathematical Biology 57(2): 345-366
Miura, H.; Tsumura, H.; Kubota, H.; Mawatari, T.; Matsuda, S.; Iwamoto, Y. 1998: Interlocking wedge osteotomy for cubitus varus deformity. Fukuoka Igaku Zasshi 89(4): 119-125
Hashimoto, H.; Iida, J.; Masui, K.; Yonezawa, T.; Sakaki, T. 1997: Interlocking-clipping technique for giant aneurysms of the internal carotid artery: technical case report. Neurosurgery 40(6): 1302-4; Discussion 1304-6
Perez Marcos, B.; Martinez Pacheco, R.; Gomez Amoza, J.L.; Souto, C.; Concheiro, A.; Rowe, R.C. 1993: Interlot variability of carbomer 934. International Journal Of Pharmaceutics (amsterdam). 100(1-3): 207-212
Guillot, P.V.; Carlier, M.; Maxson, S.C.; Roubertoux, P.L. 1995: Intermale aggression tested in two procedures, using four inbred strains of mice and their reciprocal congenics: Y chromosomal implications. Behavior Genetics 25(4): 357-360
Guillot, P.V.; Chapouthier, G. 1996: Intermale aggression and dark/light preference in ten inbred mouse strains. Behavioural Brain Research 77(1-2): 211-213
Motelica-Heino, I.; Edwards, D.A.; Roffi, J. 1993: Intermale aggression in mice: Does hour of castration after birth influence adult behavior?. Physiology and Behavior 53(5): 1017-1019
Guillot, P.V.; Chapouthier, G. 1998: Intermale aggression, GAD activity in the olfactory bulbs and Y chromosome effect in seven inbred mouse strains. Behavioural Brain Research 90(2): 203-206
LoSasso, G.L.; Rapport, L.J.; Axelrod, B.N.; Reeder, K.P. 1998: Intermanual and alternate-form equivalence on the trail making tests. Journal of Clinical and Experimental Neuropsychology 20(1): 107-110
Kwon, L.M.; Rourke, S.B.; Grant, I. 1997: Intermanual differences on motor and psychomotor tests in alcoholics: no evidence for selective right-hemisphere dysfunction. Perceptual and Motor Skills 84(2): 403-414
Thut, G.; Cook, N.D.; Regard, M.; Leenders, K.L.; Halsband, U.; Landis, T. 1996: Intermanual transfer of proximal and distal motor engrams in humans. Experimental Brain Research 108(2): 321-327
Charron, J.F.; Collin, I.; Braun, C.M. 1996: Intermanual transfer of somaesthetic information: A two-point discrimination experiment. Neuropsychologia 34(9): 873-877
Thut, G.; Halsband, U.; Roelcke, U.; Nienhusmeier, M.; Missimer, J.; Paul-Maguire, R.; Regard, M.; Landis, T.; Leenders, K., L. 1997: Intermanual transfer of training: Blood flow correlates in the human brain. Behavioural Brain Research 89(1-2): 129-134
Dunet, E.; Nallet, E.; Badjina, F.; Marx, O. 1997: Intermaxillary block in adults using pitons. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 98(Suppl 1): 103-108
Bartoli, A.; Tortosa, R., D. 1998: Intermediacy between Grindelia chiloensis and Haplopappus pectinatus (Astereae, Asteraceae). Taxon 47(2): 337-345
Odend'hal, Stewart 1993: Intermediary agricultural energetics: A case study of solar energy linkage with Chinese working cattle. Agriculture Ecosystems and Environment 43(3-4): 217-233
Hoyer, S. 1993: Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events. Progress in Neuro-Psychopharmacology and Biological Psychiatry 17(2): 199-228
Peter, V., S.; Oommen, O., V. 1992: Intermediary metabolism in castrated/thyroidectomized Calotes versicolor: Regulation of thyroxine and testosterone. Zoological Science 9(5): 1055-1060
Chin, K.J.; Conrad, R. 1995: Intermediary metabolism in methanogenic paddy soil and the influence of temperature. Fems Microbiology Ecology 18(2): 85-102
Kachinsky, A.M.; Dominov, J.A.; Miller, J.B. 1995: Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 43(8): 843-847
Weerasinghe, A.; Kawamura, T.; Moroda, T.; Seki, S.; Watanabe, H.; Abo, T. 1998: Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation. Cellular Immunology 185(1): 14-29
Osman, Y.; Watanabe, T.; Kawachi, Y.; Sato, K.; Ohtsuka, K.; Watanabe, H.; Hashimoto, S.; Moriyama, Y.; Shibata, A.; Abo, T. 1995: Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice. Cellular Immunology 166(2): 172-186
Cullen, D.J.; Nemeskal, A.R.; Zaslavsky, A.M. 1994: Intermediate TISS: a new Therapeutic Intervention Scoring System for non-ICU patients. Critical Care Medicine 22(9): 1406-1411
Kathmann, M.; Schlicker, E.; Göthert, M. 1994: Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors. Psychopharmacology 116(4): 464-468
González-García, A.; Mérida, I.; Martinez-A, C.; Carrera, A.C. 1997: Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. Journal of Biological Chemistry 272(15): 10220-10226
D.L.M.za, A.; Manich, A.M.; Parra, J.L. 1997: Intermediate aggregates resulting in the interaction of bile salt with liposomes studied by transmission electron microscopy and light scattering techniques. Journal Of Microscopy (oxford). 186(1): 75-83
Battista, C.; Panza, N.; Chiurazzi, B.; Iodice, G.; Esposito, G.; Cocorocchio, E.; Bevilacqua, N.; Pacilio, G. 1993: Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM). Biomedicine and Pharmacotherapy 47(4): 145-154
Duchateau, J.; Schreyen, H.; Dorchy, H. 1992: Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro. Diabete and Metabolisme 18(4): 272-276
Bacharach, D.W.; von Duvillard, S.P. 1995: Intermediate and long-term anaerobic performance of elite Alpine skiers. Medicine and Science in Sports and Exercise 27(3): 305-309
Alexander, C.; Bader, J.B.; Schaefer, A.; Finke, C.; Kirsch, C.M. 1998: Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 39(9): 1551-1554
Risio, M.; Rocci, M.P. 1995: Intermediate biomarkers in the colorectal tumor progression. Tumori 81(3 Suppl): 16-18
Singh, J.; Kelloff, G.; Reddy, B.S. 1993: Intermediate biomarkers of colon cancer: modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Carcinogenesis 14(4): 699-704
Rachmilewitz, J.; Gonik, B.; Goshen, R.; Ariel, I.; Schneider, T.; Eldar-Geva, T.; de Groot, N.; Hochberg, A. 1993: Intermediate cells during cytotrophoblast differentiation in vitro. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 4(5): 395-402
Lainé, J.; Axelrad, H.; Rahbi, N. 1992: Intermediate cells of Lugaro are present in the immature rat cerebellar cortex at an earlier stage than previously thought. Neuroscience Letters 145(2): 225-228
Harrison, J.W.; Roda, R.S. 1995: Intermediate cementum. Development, structure, composition, and potential functions. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 79(5): 624-633
Yao, K.W.; Schulz, H. 1996: Intermediate channeling on the trifunctional beta-oxidation complex from pig heart mitochondria. Journal of Biological Chemistry 271(30): 17816-17820
Torka, M.C.; Salefsky, B.E.; Hacker, R.W. 1995: Intermediate clinical results after aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis. Annals of Thoracic Surgery 60(2 Suppl): S311-S315
Isomura, T.; Sato, T.; Hisatomi, K.; Hayashida, N.; Maruyama, H. 1996: Intermediate clinical results of combined gastroepiploic and internal thoracic artery bypass. Annals of Thoracic Surgery 62(6): 1743-1747
Shilov, A.E. 1992: Intermediate complexes in chemical and biological nitrogen fixation. Pure and Applied Chemistry 64(10): 1409-1420
Zheng, J.; Sigworth, F.J. 1998: Intermediate conductances during deactivation of heteromultimeric Shaker potassium channels. Journal of General Physiology 112(4): 457-474
Hamada, D.; Hoshino, M.; Kataoka, M.; Fink, A.L.; Goto, Y. 1993: Intermediate conformational states of apocytochrome c. Biochemistry 32(39): 10351-10358
Collins, S.L.; Glenn, S.M. 1997: Intermediate disturbance and its relationship to within- and between-patch dynamics. New Zealand Journal of Ecology 21(1): 103-110
Zambetti, M.; Terenziani, M.; Bartoli, C.; Valagussa, P.; Piotti, P.; Ferranti, C.; Bonadonna, G. 1996: Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study. American Journal of Clinical Oncology 19(1): 82-86
Picker, M.J.; Craft, R.M.; Negus, S.S.; Powell, K.R.; Mattox, S.R.; Jones, S.R.; Hargrove, B.K.; Dykstra, L.A. 1992: Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats. Journal of Pharmacology and Experimental Therapeutics 263(2): 668-681
Bertelli, E.; Bendayan, M. 1997: Intermediate endocrine-acinar pancreatic cells in duct ligation conditions. American Journal of Physiology 273(5): C1641-C1649
Zanchetti, A. 1997: Intermediate endpoints for atherosclerosis in hypertension. Blood Pressure. Supplement 2: 97-102
Nakano, T. 1998: Intermediate epithelium. Kaibogaku Zasshi. Journal of Anatomy 73(2): 87-92
Alvarez-Gago, T.; Bullón, M.M.; Rivera, F.; Velasco, A.; Mayo, A. 1996: Intermediate filament aggregates in mitoses of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Histopathology 28(4): 349-355
Giasson, B.I.; Mushynski, W.E. 1998: Intermediate filament disassembly in cultured dorsal root ganglion neurons is associated with amino-terminal head domain phosphorylation of specific subunits. Journal of Neurochemistry 70(5): 1869-1875
Elder, M.J.; Hiscott, P.; Dart, J.K.G. 1997: Intermediate filament expression by normal and diseased human corneal epithelium. Human Pathology 28(12): 1348-1354,.
Madigan, M.C.; Penfold, P.L.; Provis, J.M.; Balind, T.K.; Billson, F.A. 1994: Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Retina 14(1): 65-74
Mayall, F.G.; Goddard, H.; Gibbs, A.R. 1992: Intermediate filament expression in mesotheliomas: Leiomyoid mesotheliomas are not uncommon. Histopathology 21(5): 453-457
Heatley, M.; White, J.; Patterson, A.; Maxwell, P.; Whiteside, C.; Toner, P. 1997: Intermediate filament expression of ductal carcinoma cells in fine needle aspirates of the breast. Acta Cytologica 41(3): 717-720
McConnell, S.J.; Yaffe, M.P. 1993: Intermediate filament formation by a yeast protein essential for organelle inheritance. Science 260(5108): 687-689
Meng, J.J.; Khan, S.; Ip, W. 1996: Intermediate filament protein domain interactions as revealed by two-hybrid screens. Journal of Biological Chemistry 271(3): 1599-1604
Coonen, E.; Dumoulin, J.C.; Ramaekers, F.C. 1993: Intermediate filament protein expression in early developmental stages of the mouse. A confocal scanning laser microscopy study of in vitro fertilized and in vitro cultured pre-implantation mouse embryos. Histochemistry 99(2): 141-149
Stuurman, N.; Sasse, B.; Fisher, P.A. 1996: Intermediate filament protein polymerization: molecular analysis of Drosophila nuclear lamin head-to-tail binding. Journal of Structural Biology 117(1): 1-15
Fröjdman, K.; Paranko, J.; Virtanen, I.; Pelliniemi, L.J. 1993: Intermediate filament proteins and epithelial differentiation in the embryonic ovary of the rat. Differentiation; Research in Biological Diversity 55(1): 47-55
Mencarelli, C.; Cotelli, F. 1997: Intermediate filament proteins immunologically related to cytokeratins in the oocyte of the fish Cyprinus carpio. Zygote 5(3): 207-212
Mermelstein, C.dos.S.; Costa, M.L.; Chagas Filho, C.; Moura Neto, V. 1996: Intermediate filament proteins in TPA-treated skeletal muscle cells in culture. Journal of Muscle Research and Cell Motility 17(2): 199-206
Johansson, B.; Eriksson, A.; Virtanen, I.; Thornell, L.E. 1997: Intermediate filament proteins in adult human arteries. Anatomical Record 247(4): 439-448
Baldi, J.C.; Reiser, P.J. 1995: Intermediate filament proteins increase during chronic stimulation of skeletal muscle. Journal of Muscle Research and Cell Motility 16(6): 587-594
Bunton, T.E. 1994: Intermediate filament reactivity in hyperplastic and neoplastic lesions from medaka (Oryzias latipes). Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 46(4-5): 389-396
James, V.J.; Wilk, K.E.; McConnell, J.F.; Baranov, E.P.; Amemiya, Y. 1995: Intermediate filament structure of alpha-keratin in baboon hair. International Journal of Biological Macromolecules 17(2): 99-104
Götz, W.; Kasper, M.; Fischer, G.; Herken, R. 1995: Intermediate filament typing of the human embryonic and fetal notochord. Cell and Tissue Research 280(2): 455-462
Hurme, R.; Namork, E.; Nurmiaho-Lassila, E.L.; Rhen, M. 1994: Intermediate filament-like network formed in vitro by a bacterial coiled coil protein. Journal of Biological Chemistry 269(14): 10675-10682
Bloom, S.; Lockard, V.G.; Bloom, M. 1996: Intermediate filament-mediated stretch-induced changes in chromatin: a hypothesis for growth initiation in cardiac myocytes. Journal of Molecular and Cellular Cardiology 28(10): 2123-2127
Chen, J.L.; Wang, P. 1994: Intermediate filament-nuclear lamina-nuclear matrix system in B cell of Peking duck. Acta Zoologica Sinica 40(4): 344-349
Real, F.X.; Vilá, M.R.; Skoudy, A.; Ramaekers, F.C.; Corominas, J.M. 1993: Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer. International Journal of Cancer 54(5): 720-727
Morgan, P.R.; Su, L. 1994: Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. European Journal of Cancer. Part B Oral Oncology 30b(3): 160-166
Herzig, K.H.; Altmannsberger, M.; Fölsch, U.R. 1994: Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 106(5): 1326-1332
de Miguel, M.P.; Bethencourt, F.R.; Arenas, M.I.; Fraile, B.; Paniagua, R. 1997: Intermediate filaments in the Sertoli cells of the ageing human testis. Virchows Archiv: An International Journal of Pathology 431(2): 131-138
Arenas, M.I.; Fraile, B.; De Miguel, M.; Paniagua, R. 1995: Intermediate filaments in the testis of the teleost mosquito fish Gambusia affinis holbrooki: A light and electron microscope immunocytochemical study and western blotting analysis. Histochemical Journal 27(4): 329-337
Singh, S.; Gupta, P.D. 1994: Intermediate filaments-heterogenous expression pattern and modulation: Can their role in structure and function of the cell be ascertained?. Biology of the Cell 82(1): 1-10
Benaroch, T.E.; Richards, B.S.; Haideri, N.; Smith, C. 1996: Intermediate follow-up of a simple method of hip arthrodesis in adolescent patients. Journal of Pediatric Orthopedics 16(1): 30-36
Gajarski, R.J.; Towbin, J.A.; Bricker, J.T.; Radovancevic, B.; Frazier, O.H.; Price, J.K.; Schowengerdt, K.O.; Denfield, S.W. 1994: Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. Journal of the American College of Cardiology 23(7): 1682-1687
Di Lazzaro, C.; Campadelli-Fiume, G.; Torrisi, M.R. 1995: Intermediate forms of glycoconjugates are present in the envelope of herpes simplex virions during their transport along the exocytic pathway. Virology 214(2): 619-623
Kellner, M.; Holsboer, F.; Heuser, I. 1995: Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression. Psychiatry Research 59(1-2): 157-160
Madsen, H.; Christensen, N.O. 1992: Intermediate hosts of schistosomes: Ecology and control. Bulletin of the Society for Vector Ecology 17(1): 2-9
Hasstedt, S.J.; Leppert, M.; Filloux, F.; van de Wetering, B.J.; McMahon, W.M. 1995: Intermediate inheritance of Tourette syndrome, assuming assortative mating. American Journal of Human Genetics 57(3): 682-689
Tsutsumi, Y.; Osamura, R.Y.; Makuuchi, H. 1996: Intermediate lymphocytic lymphoma massively involving the gastrointestinal tract. Pathology International 46(5): 380-383
Nakagawa, M.; Sugiyama, H.; Ogawa, H.; Tone, S.; Morishita, H.; Ikeda, H.; Aozasa, K.; Taniwaki, M.; Abe, T.; Kishimoto, T. 1995: Intermediate lymphocytic lymphoma with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2). Cancer Genetics and Cytogenetics 79(1): 89-91
Mitra, S.; Amazeen, P., G.; Turvey, M.T. 1998: Intermediate motor learning as decreasing active (dynamical) degrees of freedom. Human Movement Science 17(1): 17-65
Nicholson, G.; Nash, J. 1993: Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 43(12): 2558-2564
Tipton, P.A. 1993: Intermediate partitioning in the tartrate dehydrogenase-catalyzed oxidative decarboxylation of D-malate. Biochemistry 32(11): 2822-2827
Doyle, M.G.; Morrow, A.L.; Van, R.; Pickering, L.K. 1992: Intermediate resistance of Streptococcus pneumoniae to penicillin in children in day-care centers. Pediatric Infectious Disease Journal 11(10): 831-835
Hennein, H.A.; Mosca, R.S.; Urcelay, G.; Crowley, D.C.; Bove, E.L. 1995: Intermediate results after complete repair of tetralogy of Fallot in neonates. Journal of Thoracic and Cardiovascular Surgery 109(2): 332-42 344; Discussion 342-3
Turley, K.; Verrier, E., D.; (Usa), C.-Heart-Surgeons-Society-Database 1995: Intermediate results from the period of the Congenital Heart Surgeons Transposition Study: 1985 to 1989. Annals of Thoracic Surgery 60(3): 505-510
Laschinger, J.C.; Redmond, J.M.; Cameron, D.E.; Kan, J.S.; Ringel, R.E. 1996: Intermediate results of the extracardiac Fontan procedure. Annals of Thoracic Surgery 62(5): 1261-1267; Discussion: 1266-1267
Park, J.; Teichmann, S.A.; Hubbard, T.; Chothia, C. 1997: Intermediate sequences increase the detection of homology between sequences. Journal of Molecular Biology 273(1): 349-354
Schmitz, F.; Dreckhahn, D. 1993: Intermediate stages in the disassembly of synaptic ribbons in cone photoreceptors of the crucian carp, Carassius carassius. Cell and Tissue Research 272(3): 487-490
Della Longa S, D.; Ascone, I.; Fontaine, A.; Congiu Castellano, A.; Bianconi, A. 1994: Intermediate states in ligand photodissociation of carboxymyoglobin studies by dispersive X-ray absorption. European Biophysics Journal: Ebj 23(5): 361-368
Privalov, P.L. 1996: Intermediate states in protein folding. Journal of Molecular Biology 258(5): 707-725
Bonafe, C.F.; Araujo, J.R.; Silva, J.L. 1994: Intermediate states of assembly in the dissociation of gastropod hemocyanin by hydrostatic pressure. Biochemistry 33(9): 2651-2660
Richardson, D.R.; Baker, E. 1992: Intermediate steps in cellular iron uptake from transferrin. Detection of a cytoplasmic pool of iron, free of transferrin. Journal of Biological Chemistry 267(30): 21384-21389
Lundberg, K.; Heath, W.; Köntgen, F.; Carbone, F.R.; Shortman, K. 1995: Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes. Journal of Experimental Medicine 181(5): 1643-1651
Kydd, R.; Lundberg, K.; Vremec, D.; Harris, A.W.; Shortman, K. 1995: Intermediate steps in thymic positive selection. Generation of CD4-8+ T cells in culture from CD4+8+, CD4int8+, and CD4+8int thymocytes with up-regulated levels of TCR-CD3. Journal of Immunology 155(8): 3806-3814
Jacobs, M., L.; Blackstone, E., H.; Bailey, L., L.; Society, C.-Heart-Surgeons 1998: Intermediate survival in neonates with aortic atresia: A multi-institutional study. Journal of Thoracic and Cardiovascular Surgery 116(3): 417-431
De Bleecker, J.; Van den Neucker, K.; Colardyn, F. 1993: Intermediate syndrome in organophosphorus poisoning: a prospective study. Critical Care Medicine 21(11): 1706-1711
Holloway, F.B.; Farah, R.N. 1997: Intermediate term assessment of the reliability, function and patient satisfaction with the AMS700 ultrex penile prosthesis. Journal of Urology 157(5): 1687-1691
Soheilian, M.; Markomichelakis, N.; Foster, C.S. 1996: Intermediate uveitis and retinal vasculitis as manifestations of cat scratch disease. American Journal of Ophthalmology 122(4): 582-584
Johnson, A.P. 1998: Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?. Journal of Antimicrobial ChemoTherapy 42(3): 289-291
Sharma, R.; Synkewecz, C.; Raggio, T.; Mattison, D.R. 1994: Intermediate variables as determinants of adverse pregnancy outcome in high-risk inner-city populations. Journal of the National Medical Association 86(11): 857-860
Rebollo, A.; Silva, A. 1993: Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals. Immunology 80(2): 229-235
Sykes, L.R. 1996: Intermediate- and long-term earthquake prediction. Proceedings of the National Academy of Sciences of the United States of America 93(9): 3732-3739
Prieto, V.G.; Lugo, J.; McNutt, N.S. 1996: Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions. Journal of Cutaneous Pathology 23(3): 234-241
Shoji, T.; Nishizawa, Y.; Kawagishi, T.; Kawasaki, K.; Taniwaki, H.; Tabata, T.; Inoue, T.; Morii, H. 1998: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. Journal of the American Society of Nephrology: Jasn 9(7): 1277-1284
Hodis, H.N.; Mack, W.J.; Dunn, M.; Liu, C.; Liu, C.; Selzer, R.H.; Krauss, R.M. 1997: Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation 95(8): 2022-2026
Steiner, G. 1998: Intermediate-density lipoproteins, diabetes and coronary artery disease. Diabetes Research and Clinical Practice 40(Suppl): S29-S33
Maschan, A.A.; Kryzanovskii, O.I.; Yourlova, M.I.; Skorobogatova, E.V.; Pashanov, E.D.; Potapova, Y.E.; Timonova, L.A.; Bogatcheva, N.Y.; Samochatova, E.V.; Roumjantzev, A.G. 1997: Intermediate-dose busulfan and cyclophophamide as a conditioning regiment for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation. Bone Marrow Transplantation 19(4): 385-387
Rule, S.A.; Savage, D.G.; O'Brien, S.G.; Orchard, K.; McDonald, C.; Davidson, J.; Matthey, F.; Reilly, J.T.; Bardhan, G.; Miller, E.; Cranfield, T.; Apperley, J.F.; Goldman, J.M. 1996: Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemia. British Journal of Haematology 94(4): 694-698
Mahoney, D.H.; Shuster, J.; Nitschke, R.; Lauer, S.J.; Winick, N.; Steuber, C.P.; Camitta, B. 1998: Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(1): 246-254
Freeman, A.I.; Boyett, J.M.; Glicksman, A.S.; Brecher, M.L.; Leventhal, B.G.; Sinks, L.F.; Holland, J.F. 1997: Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up. Medical and Pediatric Oncology 28(2): 98-107
Velasquez, W.S.; McLaughlin, P.; Fuller, L.M.; Allen, P.K.; Tucker, S.L.; Swan, F.; Rodriguez, M.A.; Hagemeister, F.B.; Cabanillas, F.F. 1994: Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. Cancer 73(9): 2408-2416
Corn, B.W. 1996: Intermediate-risk endometrial cancer. a management approach. American Journal of Clinical Oncology 19(6): 631-635
Shaha, A.R.; Loree, T.R.; Shah, J.P. 1994: Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 116(6): 1036-40; Discussion 1040-1
Keilis-Borok, V.I. 1996: Intermediate-term earthquake prediction. Proceedings of the National Academy of Sciences of the United States of America 93(9): 3748-3755
Sano, T.; Riesenfeld, T.; Karl, T.R.; Wilkinson, J.L. 1995: Intermediate-term outcome after intracardiac repair of associated cardiac defects in patients with atrioventricular and ventriculoarterial discordance. Circulation 92(9): II272-II278
Cheung, J.C.; Wright, M.M.; Murali, S.; Pederson, J.E. 1997: Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 104(1): 143-149
Baudet, E.M.; Dromer, C.; Dubrez, J.; Jougon, J.B.; Roques, X.; Velly, J.F.; Deville, C.; Couraud, L.; Group, T.B. Lung And Heart Lung Transplant 1996: Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Journal of Thoracic and Cardiovascular Surgery 112(5): 1292-1300
Lloyd, M.A.; Baerveldt, G.; Fellenbaum, P.S.; Sidoti, P.A.; Minckler, D.S.; Martone, J.F.; LaBree, L.; Heuer, D.K. 1994: Intermediate-term results of a randomized clinical trial of the 350- versus the 500-mm2 Baerveldt implant. Ophthalmology 101(8): 1456-63; discussion 1463-4
Asahina, S.; Muneta, T.; Hoshino, A.; Niga, S.; Yamamoto, H. 1998: Intermediate-term results of meniscal repair in anterior cruciate ligament-reconstructed knees. American Journal of Sports Medicine 26(5): 688-691
Zamora, R.; Rao, P.S.; Lloyd, T.R.; Beekman, R.H.; Sideris, E.B. 1998: Intermediate-term results of phase I Food and Drug Administration trials of buttoned device occlusion of secundum atrial septal defects. Journal of the American College of Cardiology 31(3): 674-676
Hayran, M.; Sürücü, H.S. 1996: Intermediate cells detected in electron microscopic observation of the rat spiral ganglion. Okajimas Folia Anatomica Japonica 73(2-3): 109-111
Neumann, D.; Wikström, L.; Watowich, S.S.; Lodish, H.F. 1993: Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes. Journal of Biological Chemistry 268(18): 13639-13649
Pont-Kingdon, G.; Dawson, R.J.; Carroll, D. 1993: Intermediates in extrachromosomal homologous recombination in Xenopus laevis oocytes: characterization by electron microscopy. EMBO Journal 12(1): 23-34
Pak, C.C.; Krumbiegel, M.; Blumenthal, R. 1994: Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion. Journal of General Virology 75: 395-399
Amarnath, V.; Amarnath, K.; Valentine, W.M.; Eng, M.A.; Graham, D.G. 1995: Intermediates in the Paal-Knorr synthesis of pyrroles. 4-Oxoaldehydes. Chemical Research in Toxicology 8(2): 234-238
Machold, R.P.; Ploegh, H.L. 1996: Intermediates in the assembly and degradation of class I major histocompatibility complex (MHC) molecules probed with free heavy chain-specific monoclonal antibodies. Journal of Experimental Medicine 184(6): 2251-2259
Booth, P.J.; Farooq, A. 1997: Intermediates in the assembly of bacteriorhodopsin investigated by time-resolved absorption spectroscopy. European Journal of Biochemistry 246(3): 674-680
Steinebach, V.; de Vries, S.; Duine, J.A. 1996: Intermediates in the catalytic cycle of copper-quinoprotein amine oxidase from Escherichia coli. Journal of Biological Chemistry 271(10): 5580-5588
Irby, R.B.; Adair, W.L. 1994: Intermediates in the folic acid biosynthetic pathway are incorporated into molybdopterin the yeast, Pichia canadensis. Journal of Biological Chemistry 269(39): 23981-23987
Nandi, D.; Woodward, E.; Ginsburg, D.B.; Monaco, J.J. 1997: Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO Journal 16(17): 5363-5375
Madshus, I.H.; Wiedlocha, A.; Sandvig, K. 1994: Intermediates in translocation of diphtheria toxin across the plasma membrane. Journal of Biological Chemistry 269(6): 4648-4652
Hong, G.; Ward, P.; Berns, K.I. 1994: Intermediates of adeno-associated virus DNA replication in vitro. Journal of Virology 68(3): 2011-2015
Wistuba, A.; Weger, S.; Kern, A.; Kleinschmidt, J.A. 1995: Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. Journal of Virology 69(9): 5311-5319
Syrtsova, L.A.; Skvortsevich, E.G.; Uzenskaya, A.M.; Panteleeva, N.S. 1995: Intermediates of the nitrogenase ATPase reaction. Biokhimiya 60(2): 250-256
Tuhkanen, T.A.; Beltran, F.J. 1995: Intermediates of the oxidation of naphthalene in water with the combination of hydrogen peroxide and UV radiation. Chemosphere 30(8): 1463-1475
Nagamune, H.; Ohnishi, C.; Katsuura, A.; Fushitani, K.; Whiley, R.A.; Tsuji, A.; Matsuda, Y. 1996: Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infection and Immunity 64(8): 3093-3100
Senda, T.; Yoshinaga-Hirabayashi, T. 1998: Intermembrane bridges within membrane organelles revealed by quick-freeze deep-etch electron microscopy. Anatomical Record 251(3): 339-345
Kinoshita, K.; Furuike, S.; Yamazaki, M. 1998: Intermembrane distance in multilamellar vesicles of phosphatidylcholine depends on the interaction free energy between solvents and the hydrophilic segments of the membrane surface. Biophysical Chemistry 74(3): 237-249,. 14
Cajal, Y.; Rogers, J.; Berg, O.G.; Jain, M.K. 1996: Intermembrane molecular contacts by polymyxin B mediate exchange of phospholipids. Biochemistry 35(1): 299-308
Cumming, C.E.; Fox, E.E.; Cumming, D.C. 1995: Intermenstrual affect in women with symptomatic premenstrual change. Journal of Psychosomatic Research 39(3): 261-269
Atar, D.; Grant, A.D.; Lehman, W.B. 1992: Intermetatarsal synostosis after treatment with Ilizarov apparatus: a case report. Bulletin ) 52(1): 12
Cattozzo, G.; Fabi, A.; Franzini, C. 1997: Intermethod variability of sodium and potassium results: patients' sera and commercially available control sera. European Journal of Clinical Chemistry and Clinical Biochemistry 35(5): 387-392
Smits, H.L.; Bollen, L.J.; Tjong-A-Hung, S.P.; Vonk, J.; Van Der Velden, J.; Ten Kate, F.J.; Kaan, J.A.; Mol, B.W.; Ter Schegget, J. 1995: Intermethod variation in detection of human papillomavirus DNA in cervical smears. Journal of Clinical Microbiology 33(10): 2631-2636
Starostina, N.G.; Pashkova, N.I.; Gorkina, N.B.; Tsiomenko, A.B. 1994: Intermicrobe relationships among methanotrophs. Mikrobiologiya 63(3): 545-552
Bakeeva, L.E.; Brustovetskii, N.N. 1993: Intermitochondrial septate junction in hepatic cells from hibernating ground squirrels Citellus undulatus. Biologicheskie Membrany (Moscow) 10(1): 36-43
MacPhee, P.J.; Schmidt, E.E.; Groom, A.C. 1995: Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. American Journal of Physiology 269(5 Pt 1): G692-G698
Miall, R.C.; Weir, D.J.; Stein, J.F. 1993: Intermittency in human manual tracking tasks. Journal of Motor Behavior 25(1): 53-63
Pascual, M.; Ascioti, F., A.; Caswell, H. 1995: Intermittency in the plankton: A multifractal analysis of zooplankton biomass variability. Journal of Plankton Research 17(6): 1209-1232
De la Fuente, I.M.; Martinez, L.; Veguillas, J. 1996: Intermittency route to chaos in a biochemical system. Bio Systems 39(2): 87-92
Rannug, A.; Holmberg, B.; Ekström, T.; Mild, K.H.; Gimenez-Conti, I.; Slaga, T.J. 1994: Intermittent 50 Hz magnetic field and skin tumor promotion in SENCAR mice. Carcinogenesis 15(2): 153-157
Bratzke, E.; Downs, J.B.; Smith, R.A. 1998: Intermittent CPAP: a new mode of ventilation during general anesthesia. Anesthesiology 89(2): 334-340
Katsumata, T.; Nakamura, T.; Ohnishi, H.; Sakurama, T. 1995: Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 10(6): 921-931
Waxman, D.J.; Ram, P.A.; Park, S.H.; Choi, H.K. 1995: Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. Journal of Biological Chemistry 270(22): 13262-13270
Tosun, M.; Güler, M.; Erem, C.; Uslu, T.; Miskioglu, E. 1995: Intermittent Polyarthritis Due to Propylthiouracil. Clinical Rheumatology 14(5): 574-575
Podzamczer, D.; Salazar, A.; Jiménez, J.; Consiglio, E.; Santín, M.; Casanova, A.; Rufí, G.; Gudiol, F. 1995: Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Annals of Internal Medicine 122(10): 755-761